CURRICULUM VITAE NAME: Robert Lee Trestman, Ph.D., M.D. MAILING ADDRESS: Carilion Clinic 2017 S Jefferson St Roanoke VA 24014 TELEPHONE: 540-981-8597 E-MAIL: rltrestman@carilionclinic.org PLACE OF BIRTH: New Orleans, Louisiana CITIZENSHIP: U.S.A. CURRENT POSITIONS: Chair of Psychiatry and Behavioral Medicine Carilion Clinic and Virginia Tech Carilion School of Medicine 4/2017 - present

Board Secretary Academic Consortium for Criminal Justice Health http://www.accjh.org/ 10/2012 - present

EDUCATION: 9/1971-12/1974 B.S. (Chemistry and Psychology), Carnegie- Mellon University; Pittsburgh PA 9/1977-8/1981 Ph.D. (Experimental Psychology), University of Tennessee, Knoxville TN 9/1981-6/1985 M.D., University of Tennessee Health Sciences Center, Memphis TN POSTDOCTORAL TRAINING: 7/1985-6/1986 Internship, Mount Sinai Hospital, New York NY 7/1986-6/1989 Resident in Psychiatry, Mount Sinai Hospital, New York, NY 7/1988-6/1990 Veterans Administration Research Psychiatrist Trainee

Bronx VAMC and Mount Sinai Hospital, New York NY BOARD CERTIFICATION: 1992, ABPN Certificate # 36487 LICENSURE: July, 1986-June, 2000 New York State #166702 February, 1999- Connecticut #03748 HONORS: 1987-89 Sol Ginsberg Fellow to the Group for the Advancement of Psychiatry 1988-1990 Veterans Administration Research Psychiatrist Traineeship 1988 Marcel Heiman Memorial Award for Outstanding Research, Department of Psychiatry, Mount Sinai Medical Center 1992 Teacher of the Year, Department of Psychiatry, Mt. Sinai Medical Center 1993 NARSAD Young Investigator Award 1993-1997 American College of Neuropsychopharmacology (ACNP)/ Mead Johnson Travel Award 1998-2004 President, Personality Disorders Foundation 2003 Mayoral Citation and City Council Resolution, City of New Orleans, in recognition of

service to the Jewish Children’s Regional Service 2004-2006 Senior Fellow, Child Health and Development Institute 2005- Advisor, National GAINS Center for Evidence Based Programs in the Justice System 2005 Commissioned Paper in support of the Institute of Medicine’s Committee on Ethical

Considerations for Revisions to DHHS Regulations on Prisoner Research 2006-2009 Council Member, American Academy of Psychiatry and the Law 2006- Fellow, American Psychiatric Association 2007 Member, Scientific Advisory Committee, 2007 NIMH Services Research Conference 2008-2010 National Institute of Correction, Norval Morris Project Keystone Group Member 2010- Associate, Center for the Promotion of Health in the New England Workplace,

University of Massachusetts, Lowell

2

2

2012- Expert Panel Member, Justice and Health Data Exchange Initiative, Vera Institute for Justice

2012- Board Secretary, Academic Consortium for Criminal Justice Health 2013 Co-Chair, 6th Annual Academic and Health Policy Conference on Correctional Health Care, Chicago IL, March 2013 2015- Member, Board of Directors, American Academy of Psychiatry and the Law Institute 2015- Chair of the Research Committee, American Academy of Psychiatry and the Law Institute

for Education and Research 2016 American Psychiatric Association and the American Academy of Psychiatry and the Law,

Manfred S. Guttmacher Award ACADEMIC APPOINTMENTS: Active 4/2017 Professor of Psychiatry (application pending) Virginia Tech Carilion School of Medicine ACADEMIC APPOINTMENTS: Past 4/2005- 2/2007 Professor of Psychiatry with Tenure University of Connecticut School of Medicine, Farmington, CT 7/1988-6/1990 Associate in Psychiatry

Mount Sinai School of Medicine, New York NY 7/1990-12/1994 Assistant Professor of Psychiatry

Mount Sinai School of Medicine, New York NY 7/1990-6/1995 Director of Research Fellowship Training

Department of Psychiatry, Mount Sinai School of Medicine, New York NY 1/1995- 2/1999 Associate Professor of Psychiatry

Mount Sinai School of Medicine, New York NY 3/1999- 8/2001 Associate Professor of Psychiatry. University of Connecticut, Farmington, CT University of Connecticut School of Medicine, Farmington, CT 9/2001- 3/2007 Professor of Psychiatry University of Connecticut School of Medicine, Farmington, CT 4/2011- 6/2013 Director, Division of Health Policy and Legislative Outreach Center for Public Health and Health Policy University of Connecticut, Storrs CT 1/2015- 4/2016 Interim Director, UCONN Center for Public Health and Health Policy 7/2008- 9/2016 Interim Chief, Division of Occupational and Environmental Medicine (previously Public

Health and Population Sciences, Department of Medicine, UCH SOM, Farmington CT 3/2007 – 3/2017 Professor of Medicine and Psychiatry with Tenure University of Connecticut School of Medicine, Farmington, CT 7/2010- 3/2017 Professor of Nursing (Joint Appointment) University of Connecticut, Storrs CT HOSPITAL & CLINICAL APPOINTMENTS: Active 4/2017 – present Carilion Clinic HOSPITAL & CLINICAL APPOINTMENTS: Past 7/1990-12/1994 Bronx Veterans Affairs Medical Center, Bronx NY 7/1990-12/1994 Director, Psychiatry Outpatient Services

Bronx VA Medical Center, Bronx NY 1/1995- 2/1999 Mount Sinai Medical Center, New York NY 1/1995- 2/1999 Deputy Chairman, Department of Psychiatry

Mount Sinai Medical Center, New York NY 1/1996-6/1998 Clinical Director, Department of Psychiatry

Mount Sinai Medical Center, New York NY 2/1999-8/2005 Vice Chairman for Clinical Affairs, Department of Psychiatry University of Connecticut Health Center, Farmington, CT 3/1999- 8/2005 Clinical Chief of Psychiatric Services, John Dempsey Hospital, Farmington CT

3

3

3/1999-9/2002 Director, Mental Health for Correctional Managed Health Care 2001-2007 Director, Connecticut Health Signature Program 2002-2003 Connecticut Veterans Home & Hospital 7/2008-6/2009 Interim Director, Public Health Signature Program University of Connecticut Health Center, Farmington CT 7/2008-3/2011 Interim Co-Director, Center for Public Health and Health Policy University of Connecticut, Storrs CT 4/2007- 1/2017 Executive Director, UCHC Correctional Managed Health Care 3/1999- 3/2017 John Dempsey Hospital, Farmington CT PROFESSIONAL SOCIETIES: American Psychiatric Association, Fellow American Medical Association

International Society for the Study of Personality Disorders American Academy of Psychiatry and the Law

International Association for Forensic Mental Health Services American Association for Physician Leadership

Academic Consortium for Criminal Justice Health EDITORIAL BOARD: Personality and Mental Health

Journal of the American Academy of Psychiatry and the Law JOURNAL REFEREE: American Journal of Bioethics American Journal of Public Health Behavior Analysis in Offender Treatment and Prevention

Criminal Behaviour and Mental Health Criminal Justice and Behavior European Journal of Psychotherapy & Counseling

International Journal of Offender Therapy and Comparative Criminology Journal of the American Academy of Psychiatry and the Law

Journal of Clinical Psychiatry Journal of Correctional Health Care Journal of Medical Systems Journal of Offender Rehabilitation Journal of Psychiatric Research Mental Health Services Research CURRENT GRANT SUPPORT: 2016-2021 National Institutes of Health “Aging Inmates Suicidal Ideation and Depression (Aging INSIDE) Study UCH Co-Investigator: $1,993,750 PRIOR GRANT SUPPORT: 1992-1997 National Institutes of Mental Health, Institutional Training Grant

#1 T32 MH19551-01; "Research Training in Clinical Sciences" Co-Investigator Percent effort: 10%; Direct Costs: $802,000

1992- Lilly Research Laboratories; #GCO-88-244 PS/VA "Serotonergic Indicators of Fluoxetine Efficacy in the Treatment of Depression and Impulsive Aggression"; Principal Investigator; Direct Costs: $25,000

1992-1995 Department of Veterans Affairs; Merit Award #7609-014 "The Dopaminergic System in Schizotypal Personality Disorder" Co-Investigator; Percent effort: 5%; Direct Costs: $366,735

1993-1995 National Alliance for Research in Schizophrenia and Depression (NARSAD) #GCO-93-183 PS/VA; "Functional Imaging with SPECT of Cognitive Activity in Schizotypal Personality Disorder"; Principal Investigator; Direct Costs: $60,000

1993-1998 National Institutes of Mental Health, FIRST AWARD; #1 R29 MH50859-02 "5HT & NE in Aggression and Suicide in Personality Disorders" Principal Investigator; Direct Costs: $350,000

4

4

1994-1997 Janssen Research Foundation; #8593-007 "Risperidone in the Treatment of Psychotic-Like and Deficit Symptoms of Schizotypal Personality Disorder"; Principal Investigator; Direct Costs: $70,000

1998 New York Community Trust; “Infrastructure grant for the development of the Personality Disorder Foundation”; Direct Costs: $50,000

1998 United Hospitals Fund; “Special Needs Plan Standards of Care Development” Co-investigator, Direct Costs: $50,000

1998 The Ittleson Foundation; “Grant for the Development of the Personality Disorder Foundation”; Principal Investigator, Direct Costs: $30,000

1998 The Schnurmacher Family Foundations; “Grant for the Development of the Personality Disorder Foundation”; Principal Investigator, Direct Costs: $25,000

1999 The JM Foundation; “Grant for the development of a resource center for the Personality Disorders Foundation” Direct Costs: $20,000

2000 National Institute of Justice; “Justice Research, Development, and Evaluation Project” Co-Principal Investigator, Direct Costs: $750,000.00

2001 The Schnurmacher Foundation; “Grant for the Development of the Personality Disorder Foundation”; Principal Investigator, Direct Costs $25,000

2001 Janssen Pharmaceutica; “Risperidone in the Treatment of Paranoia in Incarcerated Adults” Co-Principal Investigator, Direct Costs: $113,787 National Institute of Justice; “Connecticut Correctional Health Research Program”

Principal Investigator, Direct Costs $ 2,240,925 2004-2008 National Institute of Mental Health; “Mental Health Research Infrastructure in Corrections”

Principal Investigator, Direct Costs $1,968,743 2003-2006 Department of Justice; “Community Offender Reentry Program” Evaluator, Direct Costs $1,053,507 2004-2005 Abbott Laboratories; “A Retrospective Analysis of Depakote and Depakote ER Use in the Connecticut Department of Correction”; Principal Investigator, Direct Cost $ 22,800 2005-2007 Eli Lilly and Co.; “Open Label Study of Strattera in an Adolescent Male Prison” Principal Investigator, Direct Cost $97,260 2008-2009 National Institute of Mental Health; “Mental Health Research Infrastructure in Corrections-

Supplement”; Principal Investigator, Direct Costs $280,000 2004-2010 National Institute of Mental Health

“Mental Health Research Infrastructure in Corrections” Co-Principal Investigator, Direct Costs $1,968,743

2007-2010 Eli Lilly and Co. “Costs of Criminal Justice Involvement among Persons with SMI in CT” Site Investigator 2010-2013 National Institute of Mental Health

1RC4MH091939-01, $998,861 UCHC Site PI “Connecticut Correctional Health Services Research Partnership”

2015-2017 State of Connecticut, Department of Public Health “AIDS Prevention Education Services”

UCH PI: $514,273 2014-2017 State of Connecticut, Department of Public Health “Tuberculosis (TB) Prevention and Control in State Correctional Facilities” UCH PI: $210,000 2015-2017 Children’s Fund of Connecticut

Obesity Prevention Grant Focusing on Preventing Obesity in Children from Birth through First Two Years of Life “Data Development” UCH PI: $80,000

2015-2017 Center for Medicare & Medicaid Services “UConn Health Practice Transformation Network” UCH Contributor/Co-Investigator: $5,033,923

GRANT REVIEW PANELS 2004- 2005 National Institute of Mental Health “Translational Research in Borderline Personality Disorder”

5

5

2004- 2005 National Institute of Mental Health “SBIR proposals for Web-based clinical applications”

2005- 2006 National Institute of Mental Health “Services Research Review Committee” 2005 National Institute of Mental Health “Special Emphasis Panel for IP-RISPs” 2005-2006 National Institute of Mental Health “Social and Developmental Psychology Fellowships” 2006 National Institute of Mental Health “Centers for Innovation in Services and Intervention Research” 2008 National Institute of Mental Health “Services Research in Non Specialty Settings” 2008 Academic and Health Policy Conference on Correctional Health Care 2009 National Institute of Mental Health “Individual Pre-and Post-Doctoral Fellowship Grants” 2009 National Institute of Mental Health Challenge Grant Reviewer 2010 National Institute of Mental Health “Individual Pre-and Post-Doctoral Fellowship Grants” 2011-2012 Child Health and Development Institute “Developmental Grant Applications” 2011-2013 National Institute of Mental Health “Individual Pre-and Post-Doctoral Fellowship Grants” 2012-2013 Child Health and Development Institute “Developmental Grant Applications” 2012-2013 National Institute of Mental Health Reviewer, Adult Psychopathology and Disorders of Aging Study Section 2013 American Academy of Psychiatry and the Law Institute for Education and Research Grant Application Review 2014 National Institute of Justice, Reviewer, Social Science Research on Implementation, Dissemination and Translation 2016 National Institute of Mental Health Ad-Hoc Reviewer, R15 Academic Research Enhancement Award (AREA) INTERNATIONAL GRANT REVIEW 2008 Foundation of Science and Technology of Portugal Departamento de Programas e Projectos de Investigação Científica e Desenvolvimento Tecnológico (DPPICDT)

CURRENT COMMITTEE WORK Local: 2004- Chair, University of Connecticut Physician Health Committee 2007- Member, Patient Safety System Supervisory Group 2015- Chair, School of Medicine Public Issues Council 2015- Member, UConn Health Sciences Restructuring Committee Regional: 2008- Member, CT Department of Developmental Services, Institutional Review Board 2016- Member, Northeast Osteopathic Medicine Education Network (NEOMEN) Research and

Scholarly Activity Committee National: 2004- Member, Research Committee, American Academy of Psychiatry and Law 2008- Member, Institutional and Correctional Forensic Psychiatry Committee,

American Academy of Psychiatry and Law 2008- Member, National Advisory Council, Annual Academic and Health Policy Conference on Correctional Health Care 2012- Founding Board Member, Academic Consortium for Criminal Justice Health 2012- Secretary, Academic Consortium for Criminal Justice Health

6

6

2012- Member, Research Committee, Academic Consortium for Criminal Justice Health 2013- Member, Council on Psychiatry and the Law, American Psychiatric Association 2013- Chair, Work Group on Persons with Mental Illness in the Criminal Justice System,

American Psychiatric Association 2015- Ad-hoc Member, NIMH Data Safety Monitoring Board, Panel B 2015- Member, Board of Directors, American Academy of Psychiatry and the Law Institute 2015- Chair of the Research Committee, American Academy of Psychiatry and the Law Institute For Education and Research PRIOR COMMITTEE WORK Local: 1990-1995 Chair, Psychiatry Research Fellowship Curriculum Comm, Mt. Sinai School of Medicine 1991-1999 Executive Committee, Psychiatry Research Fellowship Prgm, Mt. Sinai Schl of Medicine 1993-1999 Advisory Committee, Mt. Sinai Medical Center General Medical Clinical Research Center 1993-1999 Teaching Committee, Brain & Behavior Curriculum, Mt. Sinai School of Medicine 1995-1999 Appointments and Promotions Committee, Department of Psychiatry, Mt. Sinai SOM 1995-1999 Medical Records Committee, Mount Sinai Hospital 1995-1999 HEALTHFIRST Inc. Mental Health/Chemical Dependency Advisory Committee 1995-1999 Co-Chair, Psychiatry Services Alliance Committee of the Mt Sinai Health System 1995-1999 Member, Board of Directors, Association of the Attending Staff of the Mount Sinai Hospital 1996-1997 Member, Executive Council, Faculty Practice Associates, Mount Sinai Medical Center 1996-1999 Member, Medical Staff Working Group, Mount Sinai Health System 1997-1999 Member, Ethics Committee, Mt Sinai Health System Home Health Agency 1997-1999 Member, Interdisciplinary Clinical Pathways Steering Committee, Mt Sinai Hospital 1997-1999 Member, Physician Advisory Council, Faculty Practice Associates, Mt. Sinai Medical

Center 1998-1999 Member, Quality of Care Committee, Faculty Practice Associates Mt. Sinai Medical Center 1999-2000 Member, Credentials Committee, John Dempsey Hospital 1999-2001 Member, Clinical Governance Committee, Strategic Planning Subcommittee, John

Dempsey Hospital 1999-2007 Member, Medical Board, John Dempsey Hospital 2000 Member, Two Strategic Planning Committees, Brain and Behavioral Disorders and Public

Health Clinical Strategic Planning, John Dempsey Hospital 2000-2007 Chair, Credentials Committee, John Dempsey Hospital 2000-2001 Co-Chairman, Connecticut Health Signature Program for UCHC 2000-2001 At-Large Clinical Member, School of Medicine Council, University of CT School of Medicine 2000-2001 Member, Clinical Governance Committee (CGC), University of CT School of Medicine 2000-2001 Member, Standards Committee of the Sex Offender Policy Advisory Comm. 2000-2007 First & Second Year Medical Student Mentoring Program 2003 Member, University of Conn Institute for Public Health Planning Committee 2003-2007 Member, University of Connecticut Conflict of Interest Committee 2004 Member, UC Center for Public Health and Health Policy - Strategic Plan Team 2004-2005 Member, Appeals Committee of the School of Medicine Compensation Plan 2005-2007 Chair, Appeals Committee of the School of Medicine Compensation Plan 2006-2007 Member, JDH Baldrige Task Force Leadership Committee 2006-2007 Chair, UCHC Vision 2020 “Grow Your Own” Task Force 2007-2009 Member, Synergy Working Group 2007- Member, Patient Safety System Supervisory Group 2007-2009 Member, BEST Executive Committee 2008-2011 Member, UCHC Leadership Team for Diversity 2009-2010 Member, UConn Code of Conduct Review Committee 2009-2010 Member, Doctorate in Nursing Practice Committee, Phil Frick, APRN 2013-2015 Secondary Member, Senior Appointments and Promotions Committee Regional: 1989-1992 District APA Branch Committee on Behavioral Therapy 1991 District APA Branch Task Force on Voluntary Services to the Homeless 1994-1995 NYC Task Force on Development of Integrated Treatment Services for Borderline

7

7

Personality Disorder 1996-1999 Member, Greater New York Hospital Association, Psychiatry Advisory Committee 1996-1999 Co-Chair, Mt Sinai IPA Mental Health Network Development Committee 1997-1999 Member, Board of Directors, Managed Care Innovations, Inc. 1997-1999 Chair, Care Management and Quality Assurance Subcommittee, Managed Care

Innovations, Inc. 1997-1999 Member, Executive Committee, Managed Care Innovations, Inc. 1997-1999 Chair, Program Committee, Managed Care Innovations, Inc. 2000-2001 Member , Expert Panel on Treatment and Intervention for the CT Governor’s Blue Ribbon

Commission on Mental Health 2000-2002 Member, Medical Examining Board for State Employee Disability Retirement 2000-2003 Member, Department of Correction, Research Oversight Committee 2001-2008 Member, Connecticut Department of Mental Retardation, Institutional Review Board 2001-2005 Member, Executive Committee, Connecticut Center for Effective Practice 2001-2002 Member, CT Parole Risk Assessment Committee 2002-2003 Member, Sex Offender Policy Advisory Council II for the State of CT 2004 Member, Interagency Taskforce on Youth in Adult Corrections, Mental Health Committee 2009-2011 Member, Program Committee, Child Health and Development Institute 2009-2010 Member, Public Policy Committee, Child Health and Development Institute 2010-2012 Member, Audit Committee, Child Health and Development Institute 2011-2012 Chair, Program Committee, Child Health and Development Institute 2004-2012 Chair, Research Committee, American Academy of Psychiatry and Law 2010-2013 Member, Special Health Services Subcommittee of the CT Health Information Technology

and Exchange Advisory Committee 2012-2014 Board Chair, Child Health and Development Institute 2012-2014 Board Vice-Chair, Children’s Fund of Connecticut 2014-2016 Board Chair, Children’s Fund of Connecticut National: 2002-2004 Chair, Institutional and Correctional Forensic Psychiatry Committee,

American Academy of Psychiatry and Law 2004-2005 Member, National Institute of Justice, Guidelines Taskforce for Research in

Prison Rape 2006-2009 Councilor, American Academy of Psychiatry and the Law 2007 Member, Scientific Advisory Committee, NIMH Mental Health Services

Research Conference 2008-2010 National Institute of Correction, Norval Morris Project Keystone Group Member 2008 Member, Bureau of Justice Statistics/CMHS/NIMH Joint Advisory Group on Mental Health Data Collection in Jails and Prisons 2009 Member, National Advisory Council, American Correctional Health Services Association Annual Conference CURRENT COMMUNITY SERVICE: 2009- Board Member, Children’s Fund of Connecticut 2009- Board Member, Child Health and Development Institute PRIOR COMMUNITY SERVICE: 1990-1991 Member of Task Force on Voluntary Services to the Homeless 1994-1995 Academic Director of Task Force on Development of Integrated Treatment Services for the

Treatment of Borderline Personality Disorder in New York City 1995-1997 President, TARA- Association for Personality Disorders 1998-2005 President, Board Chair, and Co-Founder, Personality Disorders Foundation 1998-2001 Member, Clinical Advisory Board, Creative Alternatives of New York 2002-2003 Secretary, Norfolk CT Board of Education 2002-2003 Board Member, Education Connection, Litchfield, CT 2005-2006 Board Member, Norfolk CT Board of Education 2012-2014 Board Chair, Child Health and Development Institute 2014-2016 Board Chair, Children’s Fund of Connecticut

8

8

CURRENT TEACHING RESPONSIBILITIES: Medical Students: First Year

2002- Introduction to the Mental Status Examination PCM Lecture, 2 lecture hours

Second Year 2005- Mental Health Law Human Development and Health, 1 Lecture Hour 2008- Mental Status Examination with Depressed Patients

PCM Lecture, 2 lecture hours 2010- Mental Health Delivery Services Human Development and Health, 1 Lecture Hour

Residents: First Year

2002- Crash Course, Personality Disorders, 1.5 Lecture Hours 2010- Personality Disorders, Drill-Down Seminar Series, 3 lecture hours

Second Year 1999- Axis II Disorders

Psychopharmacology Didactic Seminar, 1.5 lecture hour CONSULTATIONS/ TECHNICAL ASSISTANCE: 2004-2006 Abbott Neuroscience Department of Corrections Advisory Board 2005-2007 Balint Group Leader, UCHC Department of Family Medicine 2005-2006 CT Department of Children & Families, Special Review Team for Mortality Review 2006 California Department of Corrections and Rehabilitation: Implementation and evaluation of

an evidence- based behavioral management program 2006 Florida Department of Juvenile Justice: Training, implementation and evaluation of a cognitive

Behavioral intervention in residential and detention facilities 2010 CDC/National Center for Health Statistics and the DOJ/Bureau of Justice Statistics: Correctional Health

and Healthcare- Identifying and Prioritizing Data Needs 2010-2011 Joint Compliance Officer, United States v Erie County NY Stipulated Settlement Agreement 2012-2014 Expert Panel Member, Vera Institute of Justice, Justice Health Data Exchange, NYC 2012 Correctional Services of Canada 2015-2016 Council of State Governments Justice Center 2016 Bureau of Justice Statistics 2015- Territory of Guam, Department of Corrections 2016- National Association of State Mental Health Program Directors Forensic Division INVITED PRESENTATIONS: 1. Mt. Sinai Medical Center, New York NY, Department of Psychiatry, Grand Rounds. Biological dimensions of

depression. November 1990. 2. University of Arkansas School of Medicine, Little Rock AR, Department of Psychiatry, Grand Rounds. Differential

diagnosis of depression and personality disorders. November 1991. 3. Central General Hospital. Plainview NY, Grand Rounds. Diagnosis and treatment of depression. January 1992. 4. WCBS Nightly News. Recognition and treatment of depression. October 1992 5. University of Pittsburgh, Pittsburgh PA. Department of Psychiatry, Grand Rounds. Differential biology of impulsivity,

aggression, and suicidal behavior. February 1993. 6. Department of Mental Health, Yonkers NY. Differential diagnosis and treatment of impulsive aggressive patients.

November 1993. 7. Good Morning America, TV Broadcast. Cabin Fever: Winter depressions and their treatment. January 1994. 8. Lincoln Hospital, Bronx NY. Department of Psychiatry. Grand Rounds. Differential therapeutics of refractory

depression. February 1994. 9. QAP/ Noticias TV, National News Program. Bogota Columbia. Medications for subsyndromal disorders. February

1994.

9

9

10. Mt. Sinai Medical Center, New York NY, Department of Psychiatry, Grand Rounds. Pharmacotherapy of subsyndromal disorders. March 1994.

11. Postgraduate Center for Psychotherapy/Alliance for the Mentally Ill, New York NY, Biology of borderline personality disorder. April 1994.

12. Lenox Hill Hospital, New York NY. Department of Medicine, Grand Rounds. Differential diagnosis and treatment of depression in the elderly. July 1994.

13. Public Radio International. Voices in the Family, One Hour Radio Talk Show, Host: Dr. Dan Gottlieb, Co-Discussant: Dr. Peter Cramer. September 1994.

14. National Alliance for Research on Schizophrenia and Depression (NARSAD), Annual Scientific Symposium, Chicago IL. Functional neuroimaging of cognition in schizotypal personality disorder. September 1994.

15. Alliance for the Mentally Ill of New York State, 12th Annual Conference. Biology of Borderline Personality Disorder. November 1994.

16. Montefiore Medical Center, Bronx NY. Department of Psychiatry, Outpatient Rounds. Differential pharmacotherapy of mood disorders. December 1994.

17. New York Academy of Medicine, Biology of Borderline Personality Disorder in the conference Dialectical Behavior Therapy of Borderline Personality Disorder. December 1994.

18. Wyeth-Ayerst Visiting Professor, New York NY. Serotonergic and Noradrenergic Abnormalities in the Severe Mood Disorders. January 1995.

19. Department of Psychology, Brooklyn College of the CUNY. Psychobiology of Personality Disorders. April 1995. 20. Project Reachout, New York. Recognition and Treatment of Severe Personality Disorder among the Mentally Ill

Homeless. June 1995. 21. Harlem Hospital, New York NY. Department of Psychiatry Grand Rounds. The Psychopharmacology of Borderline

Personality Disorder. December 1995. 22. Woodhull Hospital Center, Brooklyn NY. Department of Psychiatry Grand Rounds. The Psychobiology and

Psychopharmacology of Severe Personality Disorders. January 1996. 23. University of Cincinnati, Cincinnati OH. Department of Psychiatry Grand Rounds. The Psychobiology and

Psychopharmacology of Borderline Personality Disorder. January 1996. 24. SmithKline Beecham, New York NY. Presentation to Primary Care Physicians: Anxiety and Depression:

Presentation, Diagnosis, and Treatment. May, 1997 25. Cabrini Medical Center, Department of Psychiatry Grand Rounds. The Psychopharmacology of Severe Personality

Disorder. June 1997. 26 Roerig Pharmaceuticals, New York NY. Mental Health Delivery Systems. October, 1997 27. Voluntary Attending Staff, Mt. Sinai Medical Center, The Pharmacotherapy of Anxiety Disorders, October, 1997. 28. Creedmoor Psychiatric Center, Queens Village NY. The Differential Diagnosis and Pharmacology of Severe

Personality Disorder. November 1997. 29. Pilgrim Psychiatric Center, West Brentwood, NY. Psychiatry Grand Rounds: The Treatment of Affective Lability.

December 1997. 30. FEGS, New York NY. Medical Grand Rounds: Medical Necessity in the Era of Managed Care. February 1998. 31. State of California, Department of Health, Consultant reviewer for Alzheimer’s Disease Research and Clinical Care

Centers. February 1998 32. Pilgrim Psychiatric Center, West Brentwood, NY. Psychiatry Grand Rounds: The Treatment of Impulsive

Aggression. March 1998. 33. Dartmouth Medical Center, Lebanon, NH. Psychiatry Grand Rounds. Treatment Opportunities for Impulsivity and

Affective Instability. August 1998. 34. Robert Wood Johnson Medical School, New Brunswick NJ. Psychiatry Grand Rounds. Diagnostic and Treatment

Issues in Affective Lability and Impulsivity. October 1998. 35. University of Connecticut Health Center, Department of Psychiatry, Psychiatry Grand Rounds. Implications and

Opportunities for the Treatment of Severe Personality Disorders. December 1998. 36. Institute for Behavioral Healthcare, “Provider Sponsored Solutions for Integrating Systems, Academic MBHO’s and

Community-Based Organizations. Managed Care for Special Needs Populations: Role of the Academic Medical Center in a Provider Sponsored Network. Co-Presenter: Cindy Freidmutter, Esq. McLean, VA. January, 1999.

37. Mental Health Association, Bloomfield, CT Radio interview Self-Mutilatory Behavior. What causes it? What can be done about it?” August, 1999.

38. Mental Health Association, Bloomfield, CT. Radio interview Personality Disorders: What they are and how they can be helped. September, 1999.

39. WVIT Channel 30, 11:00 p.m. News, Hartford, CT. Television interview Jealousy and Envy. February, 2000.

10

10

40. University of Connecticut Health Center, Department of Psychiatry Grand Rounds. What to do? Bioethical issues surrounding clinical staff action and subsequent cardiac arrest in a patient on DNR status. January, 2001.

41. Division of Mental Health Services, Yale University, Department of Psychiatry, New Haven, CT. Behavioral Treatment of the Aggressive and Disciplinary Problematic Mentally Ill Inmates. January, 2001.

42. Charlotte Hungerford Hospital, Family Issues Association of Northwest Connecticut, Torrington, CT. Recognition and Treatment of Bipolar Disorder: Family Issues. January, 2001.

43. Guest lecture at Capitol Region Mental Health Center, Treatment of Aggression in Public Sector Care for Severely Mentally Ill. Sponsored by AstraZeneca, March, 2001.

44. Invited guest to participate in the Second Criminal Justice Advisory Panel meeting, Miami, FL, February, 2002. 45. University of Mississippi, Department of Psychiatry, Grand Rounds: “Psychiatric Services Research in Corrections”,

April, 2002. 46. University of Massachusetts, Department of Psychiatry, Grand Rounds, “Mentally Ill Offenders: Providing

Treatment in a Correctional Environment” and Workshop “Personality Disordered Inmates: Helping the Patient and Helping the System”, April, 2002.

47. National Institute of Justice, Professional Conference Series, “Empirical Development of Mental Health Screening in Correctional Settings”, Washington, DC, July, 2002.

48. Mental Health Association of CT., St. Thomas Seminary, “Borderline Personality Disorders”, Wethersfield, CT, July 16, 2002.

49. West Hartford Community Television, “Mental Health Discussions”, West Hartford, CT, September 6, 23, 27, 2002. 50. Correctional Medical and Mental Health Care Symposium, “Assessing, managing and reducing suicide risk in jails

and prisons. “ Saratoga Springs. NY, October 2002 51. Connecticut Juvenile Training School- Topics in Juvenile Justice, “Suicide prevention in the juvenile offender

population.” Middletown, CT, November, 2002 52. WVIT Channel 30, Nightly News. “Depression & Menopause” Jan 13, 2003 53. New Haven Register; New Britain Press; Bristol Press. “Care for psychiatric patients in nursing homes” March 3,

2003 54. Waterbury Republican American. “Power and corruption” March 21, 2003 55. Temple University, Department of Psychiatry Grand Rounds, “Borderline Personality Behind Bars: Helping the

patient and helping the system” April 2003 56. WVIT Channel 30, 11:00 p.m. News, Hartford, CT. Television interview, “When Parents are Away: Preparing

Children for Extended Separation. September, 2003 57. NBC-30 (live interview) Nightly News. “Advice to couples in sexless marriages” November 19, 2003 58. Video House Calls – cable programming Northwestern CT. “Depression during the holidays” December 18, 2003 59. WTIC-AM (live interview). “Depression during the holidays” December 23, 2003 60. University of Connecticut Health Center, Department of Psychiatry, Grand Rounds, “Severe and Persistent Mental

Illness - Continuity and Complexity in a Specific Case”, January 2004 61. NBC Channel 30, News, Hartford CT. Television Interview, “Sports Violence: How Parents Can Help.” March 11,

2004 62. Rockland State Hospital, Grand Rounds, “Treating the Difficult to Treat Patient with Borderline Personality

Disorder,” Orangeburg, NY April 28, 2004 63. Danbury Hospital Grand Rounds, “Treatment of Aggression,” Danbury Ct, April 29, 2004 64. NCCHC Conference, Las Vegas NV. “Bipolar Disorder in Jails and Prisons: What you need to know”. July 12,

2004 65. Abbott Neuroscience, National Specialty Account Executives Meeting, Chicago IL, “Mental Illness in Jails and

Prisons.” August 19, 2004 66. University of Connecticut Health Center, “Panel on Health Disparities”, October 2004 67. Viewpoints (Syndicated Radio Public Health Show), “Rude and Violent Behavior at Sporting Events,” October-

November, 2004 68. National Institute of Drug Abuse, “Developing Efficacious Behavioral Therapies for Criminal Justice Involved

Populations: the Development of Corrections Modified Dialectical Behavior Therapy.” Gaithersburg Maryland, December 2004

69. Pennsylvania Department of Correction Mental Health Conference, “Pharmacologic Management of Incarcerated Patients with Bipolar Disorder,” Harrisburg PA, February 23, 2005

70. Cedarcrest State Hospital, “Treating Patients with Severe Borderline Personality Disorder,” Newington, CT March 10, 2005

71. Abbott Neuroscience, CME Conference, “Difficult Challenges: Mood Disorders in Correctional Settings,” Atlanta GA, June 4, 2005

11

11

72. Eastern Connecticut Health Network, Psychiatry Grand Rounds, “Treating the Difficult to Treat Patient with Borderline Personality Disorder,” Manchester CT, June 10, 2005

73. Office of the Attorney General, “Parental Mental Illness and Child Protective Services: Challenges and Opportunities,” Madison CT, June 17, 2005

74. New York State Department of Correctional Services, “Managing Impulsive Aggression in Correctional Settings,” Fishkill NY, June 21, 2005

75. Norwalk Hospital, Psychiatry Grand Rounds, “Borderline Personality Disorder,” Norwalk CT, September 9, 2005. 76. Cedarcrest State Hospital, “Impulsivity and Aggression,” Newington CT, September 22, 2005 77. Capital Region Mental Health Center, “Impulsivity and Aggression,” Hartford CT, September 28, 2005 78. Berkshire Medical Group, “Treating the Difficult to Treat Patient with Borderline Personality Disorder,” Lenox MA,

November 15, 2005 79. Florida Juvenile Justice Association and the Florida Alcohol and Drug Abuse Association “Adolescent Treatment

Issues Conference,” Plenary Speech: Troubled Youth, Drugs and Empowerment: The Role of Cognitive Behavioral Therapy to Facilitate Change,” Tampa FL, March 2, 2006

80. Fox61 News@10, Television Interview, “The UCHC Patient School,” March 6, 2006 81. Capital Region Mental Health Center, “Community Reintegration of Mentally Ill Offenders,” Hartford CT, March 14,

2006 82. CT Freedom of Information Commission Annual Conference, “ Difficult Issues, Difficult People, Difficult Times,”

Keynote Address, Westbrook CT, April 4, 2006 83. WWUH University of Hartford Radio, Mind Matters talk show, “Prisoners with Mental Illness,” Sunday April 30,

2006. 84. Central New York Psychiatric Center Statewide MSO Meeting, “Optimizing Psychiatric Care for Prisoners”, New

Hartford NY, May 10, 2006 85. International Society for the Study of Personality Disorders, 7th Congress, “Imprisonment of the Personality

Disordered: Challenges and Opportunities, Plenary Presentation, Prague Check Republic, June 9, 2006. 86. American Psychiatric Nurses Association, Clinical Psychopharmacology Institute, Pharmacologic Treatment of

ADHD in Correctional Settings,” Cambridge MA, June 23, 2006 87. American Psychiatric Nurses Association, Clinical Psychopharmacology Institute, “Current Approaches to

Psychopharmacology of Borderline Personality Disorder,” Cambridge MA, June 23, 2006 88. NBC News Channel 30, Connecticut, Television Interview, “The UCHC Patient School,” February 5, 2007 89. CT Psychiatry Resident Day, “Psychiatry Behind Bars: The Needs, Challenges and Opportunities,” West Hartford

CT, April 10, 2007 90. University of Massachusetts Medical School 2nd Annual Conference on Correctional Health, Plenary Speech,

“Corrections Specific Translational Research,” Quincy MA, Friday March 28, 2008 91. New York University, Tri-State AAPL Annual British-American Conference, Plenary Speech, “Personality Disorders

in Correctional Settings,” New York NY, April 12, 2008 92. Association of State Correctional Administrators, Research and Technology Committee, “START NOW:

Background, Current Status and Next Steps,” Wethersfield CT, October 29, 2008 93. American Correctional Health Services Association, Plenary Speech, “Crisis of Oral Health in Corrections: Policy

Implications”, Orlando FL, March 14 2009 94. UCHC Discovery Series, “Managing Stress and Anxiety,” Farmington CT, May 12, 2009 95. CMHC Mental Health Conference, “Evidence Based Practice in Corrections: Impulsive Aggression and Self

Injurious Behavior,” May 14, 2009 96. National Association of State Forensic Mental Health Program Directors Annual Meeting, Plenary Speech,

“Psychopharm Formulary: The Right Medicine, At The Right Time, and On Budget,” Virginia Beach, VA, September 30, 2009.

97. WNPR, Colin McEnroe Show, “Dealing with the Holiday Blues,” Hartford CT, December 9, 2009 98. NBC News Channel 30, Connecticut, Television Interview, “The Problem Gambler and March Madness,” March 22,

2010 99. APA Annual Meeting, “Managing the Aggressive/ Disruptive Inmate,” in Advances in Correctional Psychiatry, Chair:

Charles Scott, New Orleans, May 24, 2010 100. National Center for Health Statistics, “Correctional Health and Healthcare: Epidemiology of Mental Illness and

Process of Service Delivery,” Hyattsville, MD, June 28-29, 2010. 101. Jewish Children’s Regional Service Annual Meeting, “Overcoming Adversity,” New Orleans LA, March 27, 2011 102. The Police Commissioners of CT, “The Public Health Implications of Correctional Health Care,” Hamden CT, March

30, 2011

12

12

103. UCHC High School Clinical Career Day, Guidance Counselors, “Keeping your Shining Stars from Burning Out: Support for Achievers and Overachievers,” Farmington Ct, April 1, 2011

104. NIMH Conference on Mental Health Services Research, Plenary Speaker, “Translating Research into Systemic Solutions to Improve Mental Health Care,” Washington DC, July 28, 2011

105. Justice Health of New South Wales, “Correctional Mental Health Care in Connecticut USA,” Sydney Australia, September 5, 2011.

106. UConn Premed Student Club, “Medical Education and Medical Care: Current Challenges and Opportunities,” Storrs CT, November 8, 2011.

107. Academic & Health Policy Conference on Correctional Health in Atlanta, GA, March 22-24, 2012. 108. UCHC Schwartz Center Rounds, “Informed Dissent and the Right to Refuse Surgery: Is it Reasonable?” March 19,

2012. 109. Podcast, Journal of Correctional Healthcare: Recidivism Rates Among Mentally Ill Inmates: Impact of the

Connecticut Offender Reentry Program”, http://jcx.sagepub.com/content/18/1/20/suppl/DC1 April 10, 2012. 110. 8th Annual Yale NEA-BPD Conference, Borderline Personality Disorder: Impulsivity, Aggression and Legal

Involvement, Plenary Speaker, “Dialectical Behavior Therapy- Corrections Modified and START NOW,” New Haven CT, May 4, 2012.

111. WNPR, Colin McEnroe Show, “Prison Love: It May be Different Than You Think,” Hartford CT, June 20, 2012 http://www.yourpublicmedia.org/node/20562

112. Correctional Services of Canada, Management of Extreme Behaviors, Abbotsford BC, Canada, October 16, 2012 113. University of Medicine and Dentistry of New Jersey and the New Jersey Department of Corrections, “Psychiatric

Assessment and Management of Chronic Pain in Correctional Settings,” Trenton NJ February 18, 2013. 114. University of Connecticut Health Center, Center for Public Health and Health Policy. Brown Bag series –

“Correctional Health Services Research: Opportunities for Improving the Public’s Health and its Healthcare”, Farmington, CT, March 7, 2013.

115. University of Connecticut TEDX Conference. “Influencing violence in the Years Ahead.” UConn Storrs Campus, September 21, 2013.

116. Central New York Psychiatric Center in Marcy, NY, “Motivational interviewing: Applications in START NOW”, September 26, 2013.

117. University of Edinbugh, Correctional Psychiatry, Clinical Forum, Coatsbridge, Scotland, November 11, 2014. 118. University of Basel, Why START NOW? A clinical approach to skills, affirmation and strength. Department of

Forensic Psychiatry, Basel, Switzerland, November 13, 2014. 119. University of Basil, Ethical issues in correctional psychiatry. Division of Bioethics, Basel, Switzerland, November

14, 2014. 120. New York State Correctional Mental Health Staff, “Correctional Mental Health: A Best Practices Sampler”,

December 10, 2014. 121. University of Connecticut, Human Rights Institute, “Constrained Choice,” UConn Storrs Campus, April 1, 2015. 122. John Jay College of Criminal Justice, “Treating the Mentally Ill Behind Bars,” New York City, May 4, 2015. 123. Vera Institute of Justice Advisory Board Meeting, panel member for “A Sentinel Events Approach to Addressing

Suicide and Self-Harm in Jail,” New York City, June 1, 2015. 124. Council of State Governments (CSG) Justice Center Headquarters, “Reducing Recidivism and Promoting

Recovery: Research to Practice for Judges,” New York City, June 23, 2015. 125. New York State Office of Mental Health. “Evidence based practice.” Albany, NY, September 25, 2015. 126. Congressional Briefing, United States House of Representatives, Rayburn Office Building “Decriminalizing Mental

Illness.” Washington, D.C., October 29, 2015. 127. Ninth Circuit Corrections Summit, United States Court of Appeals for the Ninth Circuit, “Treatment of the Mentally Ill

During Incarceration.” Sacramento, CA. November 4-5, 2015. 128. Connecticut Law Review Symposium on Criminal Justice Reform, University of Connecticut School of Law, “Mental

Illness and Incarceration.” Hartford, CT. November 6, 2015. 129. UConn Health, Center for Quantitative Medicine/Center for Public Health and Health Policy Brown Bag Lunch

Seminar Series, “Health Care behind Locked Doors: Correctional Health Care Can Inform the American Healthcare Debate.” Farmington, CT. December 14, 2015.

130. UConn Health, Psychiatry Grand Rounds, “The development, implementation, and dissemination of a skills based psychotherapy for justice-involved people.” Farmington, CT. January 8, 2016.

131. Academic Health & Policy Conference on Correctional Health,1st Quarter Board of Directors Meeting, Baltimore, MD, March 16, 2016

132. Yale University, Department of Psychology, Invited Lecture, ”Mental Illness and Criminality,” in the undergraduate course “Criminal Minds.” New Haven CT, April 7, 2016

13

13

133. Stepping Up Initiative, “Mental Health Screening and Assessment”, Council of States Governments, National Association of Counties, and the American Psychiatric Association, Washington DC, April 18, 2016.

134. American Psychiatric Association Annual Meeting, Manfred S. Guttmacher Award Lecture for outstanding contributions to the literature of forensic psychiatry as editor of the Oxford Textbook of Correctional Psychiatry, Atlanta, Georgia, May 14, 2016,

135. American Psychiatric Association Annual Meeting, Presidential Symposium, “Correctional Psychiatry: Journey Into the Heart of Darkness,” Atlanta, Georgia, May 17, 2016

136. National Association of State Mental Health Program Directors Forensic Division, “Adaptation of START NOW for use in Forensic Psychiatric Settings,” October 3, 2016.

PUBLICATIONS: Original Peer-Reviewed Reports: 1. *Trestman RL, Heinemann MA, Whitaker JN and Seyer JM. Hormonal and drug effects on the degradation by rat

renal alkaline proteinase of human myelin basic protein peptide 43-88. Biochemical Pharmacology, 34(8): 1231-1237, 1985.

2. *Trestman RL and Stein M. Stress, infection and the immune system. Infections in Medicine, 8:17-22, 1991. 3. *Trestman RL, Coccaro EF, Bernstein D, Lawrence T, Gabriel S, Horvath TB, and Siever LJ. Cortisol Responses

to mental arithmetic in acute and remitted depression. Biological Psychiatry, 29:1051-1054, 1991. 4. Halper JP, Miller AH, Trestman RL, Santucci AC, Lackner C, and Stein M. Biochemical mechanisms of stress-

induced impairment of rat T-cell mitogenesis. Journal of Neuroimmunology, 32:241-247, 1991. 5. Stein M, Miller AH, and Trestman RL. Depression and immune function: A critical review. Archives of General

Psychiatry, 48:171-177, 1991. 6. Siever LJ, Trestman RL, Coccaro EF, Bernstein D, Gabriel SM, Owen K, Moran M, Lawrence T, Rosenthal J, and

Horvath TB. The growth hormone response to clonidine in acute and remitted depressed male patients. Journal of Neuropsychopharmacology, 6:165-177, 1992.

7. Kramer TAM and Trestman RL. A didactic program for fellowships in psychiatric research. Academic Psychiatry, 15:172-173, 1991.

8. Miller AH, Spencer RL, Trestman RL, Kim C, McEwan B, and Stein M. Adrenal steroid receptor activation in vivo and immune function. American Journal of Physiology, 261:E126-131, 1991.

9. Coccaro EF, Lawrence TL, Trestman RL, Gabriel S, Klar H, Siever LJ. Growth hormone response to intravenous clonidine challenge correlates with behavioral irritability in psychiatric patients and healthy volunteers. Psychiatry Research, 39:129-139, 1991.

10. Siever LJ, Amin F, Coccaro EF, Trestman RL, Silverman J, Horvath TB, Mahon TR, Knott P, Davidson M, Davis KL. Cerebrospinal fluid homovanillic acid in schizotypal personality disorder. American Journal of Psychiatry, 150:149-151, 1993.

11. *Trestman RL, Lawrence TL, Coccaro EF, Harvey P, Bernstein D, Lawrence EK, Condello V, Mahon T, Yang R-K, Knott P, Horvath TB, Siever LJ. Noradrenergic responses to clonidine in acute and remitted depressed male patients. Psychiatry Research, 43:199-213, 1992.

12. Wemm KM, Trestman RL, Levine S. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients. Psychosomatics, 32:470-471, 1991.

13. Siever LJ, Kahn RS, Lawlor BA, Trestman RL, Lawrence TL, Coccaro EF. Critical issues in defining the role of serotonin in the psychiatric disorders. Pharmacologic Reviews, 43:509-526, 1991.

14. Siever LJ, Trestman RL, Silverman J. Validation of personality disorder assessment by biologic and family studies. J Personality Disorders, 6:301-312, 1992.

15. *Trestman RL, Coccaro EF, Bernstein D, Lawrence TL, Knott P, Horvath TB, Siever LJ. Norepinephrine responses to postural and isometric stressors in acute and remitted depression. Psychiatry Research, 47:291-293, 1993.

16. Weiner M, Muttakin MH, Risser RC, Trestman RL. Cortisol secretion in remitted late-life depressives, Biol Psychiatry, 33:560-561, 1993.

17. *Trestman RL, Coccaro EF, Mitropoulou V, Gabriel SM, Horvath T, Siever LJ. The cortisol response to clonidine in acute and remitted depressed male patients. Biological Psychiatry, 34:373-379, 1993.

18. Kahn R, Trestman RL, Lawler B, Davidson M, Siever LJ. Effects of ipsapirone in healthy controls: A dose response study, Psychopharmacology, 114:155-160, 1994.

19. Siever LJ, Coccaro EF, Trestman RL, Gabriel S. Use of serotonin-selective agents in other psychiatric disorders. Clin Neuropharmacol, 15 Suppl 1:355-356.

20. *Trestman RL, Coccaro EF, Lawrence TL, Knott P, Gabriel SM, Siever LJ. The stability of plasma growth hormone, MHPG, and cortisol responses to repeated clonidine challenge in normal males. Psychoneuroendocrinology, 19:13-20, 1994.

14

14

21. Siever LJ, Friedman L, Moscowitz J, Mitropoulou V, Keefe R, Roitman SL, Merhige D, Trestman RL, Silverman J, Mohs R. Eye movement impairment and schizotypal psychopathology. Amer J Psychiatry, 151:1209-1215, 1994.

22. *Trestman RL, Yehuda R, Coccaro E, Knott P, Gabriel S, Siever LJ. Diurnal neuroendocrine, noradrenergic, and autonomic dysregulation in major depression. Biol Psychiatry. 37:448-456, 1995.

23. Larry J. Siever, Merril Rotter, Miklos Losonczy, Song Ling Guo, Vivian Mitropoulou, Robert L. Trestman, Seth Apter, Zvi Zemishlany, Jeremy Silverman, Michael Davidson, Kenneth L. Davis. Lateral ventrical enlargement in schizotypal personality disorder. Psychiatry Research, 57:109-118, 1995.

24. Yehuda R, Teicher MH, Levengood R, Trestman RL, Siever LJ. Circadian regulation of basal cortisol levels in posttraumatic stress disorder. Ann NY Acad Sciences, 746:378-380, 1994.

25. *Trestman RL, Keefe RSE, deVegvar ML, Harvey P, Davidson M, Siever LJ. Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder patients. Psychiatry Research, 59:127-236, 1995.

26. Yehuda R, Teicher MH, Levengood RA, Trestman RL, Siever LJ. Circadian regulation of basal cortisol levels in posttraumatic stress disorder. In Brain Corticosteroid Receptors and Function (Vol 746) of the Annals of the New York Academy of Sciences, pp 378-380, 1994.

27. Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ. Hormonal responses to m-CPP challenge are undiminished by acute m-CPP pretreatment. Psychiatry Research, 62:139-145, 1996.

28. Siever L, Trestman RL, The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol, 8 Suppl 2:33-39, 1993.

29. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in post-traumatic stress disorder: A chronobiological analysis. Biological Psychiatry, 40:79-88, 1996.

30. Stein DJ, Trestman RL, Coccaro EF, Mitropoulou V, Hollander E, Siever LJ. Serotonergic responsivity in obsessive-compulsive personality disorder. J Neuropsych & Clin Neurosciences, 8:393-398, 1996.

31. New AS, Trestman RL, Siever LJ. The pharmacotherapy of borderline personality disorder. CNS Drugs, 2:347-354, 1994.

32. Siegel BV, Trestman RL, Amin F, Kirrane R, Silverman J, Schmeidler J, Keefe RSE, Siever LJ. D-Amphetamine challenge effects on Wisconsin Card Sort Test performance in schizotypal personality disorder. Schizophrenia Research, 20:29-32, 1996.

33. Buchsbaum MS, Trestman RL, Hazlett E, Siegel BV, Shaefer CH, Luu C, Tang C, Herrera S, Solimando AC, Losonczy M, Serby M, Silverman J, Siever LJ. Regional cerebral blood flow during Wisconsin Card Sorting Test in schizotypal personality disorder. Schizophrenia Research, 27:21-28, 1997.

34. Steinberg BJ, Trestman RL, Mitropoulou V, Siever LJ. Depressive response to Physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology, 17:264-273, 1997.

35. Bergman, A, Harvey P, Mitropoulou V, Aronson A, Marder D, Trestman RL, Siever LJ. The factor structure of schizotypal symptoms in a clinical population. Schizophrenia Bulletin, 22:501-509, 1996.

36. *Trestman RL, Horvath TB, Kalus O, Peterson AA, Coccaro EF, Mitropoulou V, Apter S, Davidson M, Siever LJ. Event related potentials in schizotypal personality disorder. Jrnl Neuropsychiatry and Clinical Neurosciences, 8:33-40, 1996.

37. New AS, Trestman RL, Mitropoulou V, Benishay DS, Coccaro EF, Silverman J, and Siever LJ. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res, 69:17-26, 1997.

38. *Trestman RL. Clinical correlates and predictors of violence in patients with personality disorders. Psychiatric Annals, 27:741-744. 1997.

39. Coccaro EF, Kavoussi RJ, Trestman RL, Kanof PD, Gabriel SM, Cooper TB, Siever LJ. Serotonin function in human subjects: Intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res., 73:1-14, 1997.

40. New AS, Gelernter J, Yovell Y, Trestman RL, Nielsen DA, Silverman J, Mitropoulou V, Siever L. Tryptophan hydroxylase genotype is associated with impulsive aggressive measures: a preliminary study. Am J Med Genet (Neuropsychiatric Genetics), 81:13-17, 1998.

41. New AS, Sevin EM, Mitropoulou V, Reynolds D, Novotny SL, Callahan A, Trestman RL, Siever LJ. Serum cholesterol and impulsivity in personality disorders. Psychiatry Res, 22:85(2):145-50, 1999.

42. Koenigsberg HW, Reynolds D, Goodman M, New AS, Mitropoulou V, Trestman RL, Silverman J, Siever LJ. Risperidone in the treatment of schizotypal personality disorder. J. Clin Psychiatry 64(6): 628-634, 2003

43. Mitropoulou V, Trestman RL, New AS, Flory JD, Silverman JM, Siever LJ. Neurobiologic Function and Personality Traits in Subjects with Personality Disorders. CNS Spectrums 8(10) 725-730, 2003

44. Ford JD, Trestman RL, Steinberg, KL, Tennen H, Allen, S. Prospective Association of Anxiety, Depressive, and Addictive Disorders with High Utilization of Primary, Specialty, and Emergency Medical Care. Health Psychology Social Science & Medicine. 58: 2145-2148, 2004

15

15

45. Gaftanyuk O, *Trestman RL. Scopolamine Patch in the Treatment of Clozapine-induced Sialorrhea. Psychiatric Services. 55:318, 2004

46. Berzins L, *Trestman RL. The Development and Implementation of Corrections-Modified Dialectical Behavioral Therapy. International Journal of Forensic Mental Health 3(1): 95-105, 2004

47. New A, Trestman RL, Mitropoulou V, Goodman M, Koenigsberg HH, Silverman J & Siever LJ. Low prolactin response to fenfluramine in impulsive aggression, Journal of Psychiatric Research, Volume 38 (3): 223-230, 2004

48. Ford JD, Trestman RL, Tennen H, Allen S. Relationship of Anxiety, Depression and Alcohol Use Disorders to Persistent High Utilization and Potentially Problematic Low Utilization of Primary Medical Care. Social Science & Medicine 61 (2005) 1618–1625

49. *Trestman RL, Sevarino K, Kelly M. Management of Psychiatric Issues in Patients with Intellectual Disability, Journal of the Connecticut Medical Society, 68(8): 495-498, 2004

50. Arias A, Steinberg K, Banga A, Trestman RL. Systematic Review of the Efficacy of Meditation as Treatments for Medical Illness. Journal of Alternative and Complementary Medicine, 12:8, 817–832, 2006.

51. Ford JD, Trestman RL, Hogan V, Zhang W. “Development and Validation of a Brief Mental Health Screening Instrument for Newly Incarcerated Adults”, Assessment, 14(3):279-99, 2007.

52. Erickson SK, Rosenheck, RA, Trestman RL, Ford JD, Desai, RA. Risk of Incarceration Between Cohorts of Veterans With and Without Mental Illness Discharged From Inpatient Units. Psych Services, 59:2, 178-183, 2008.

53. Kamath J, Temporini H, Quarti S, Zhang W, Pagano K, Dematinis N, *Trestman RL. Psychiatric Use and Utility of Divalproex Sodium in Connecticut Prisons. Int J Offender Ther Comp Criminol. 2007 Sep 24 epub; print version: Int J Offender Ther Comp Criminol 2008; 52; 358

54. *Trestman RL, Ford JD, Zhang W, Hogan V. Current and Lifetime Psychiatric Illness among Inmates not Identified as Acutely Mentally Ill at Intake in Connecticut’s Jails. Journal of The American Academy of Psychiatry and the Law, 35:490-500, 2007.

55. Sampl, S., Wakai, S., Trestman, R.L., Keeney, E.M. (2008). Functional Analysis of Behavior in Corrections: Empowering Inmates in Skills Training Groups. Journal of Behavioral Analysis of Offender and Victim Treatment and Prevention, 1(4), 42-51.

56. Ford JD, Trestman RL, Weisbrok V, Zhang W. Validation of a Brief Screening Instrument for Identifying Psychiatric Disorders Among Newly Incarcerated Adults. Psychiatric Services, 60(6):842-6, 2009.

57. McClure M, Trestman RL, Koenigsberg H, Goodman M, New A, Silverman J, Siever L. The Effects of Risperidone on the Cognitive Performance of Individuals with Schizotypal Personality Disorder, Journal of Clin Psychopharm, 24:396-398, 2009.

58. Wakai S, Shelton D, Trestman RL, Kesten K. Conducting Research in Corrections: Challenges and Solutions. Behavioral Sciences and the Law, 27:743-52, 2009.

59. Shelton D, Sampl S, Kesten K, Zhang W, Trestman RL. Treatment of Impulsive Aggression in Correctional Settings. Behavioral Sciences and the Law, 27:787-800, 2009.

60. Kamath J, Shelton D, Wakai S, Kesten K, Zhang W, Trestman RL. Disseminating Best Practices for Bipolar Disorder Treatment in a Correctional Population. Psych Services, 61(9):865-867, 2010.

61. Sampl S, Wakai S, Trestman RL. Translating evidence-based practices from community to corrections: An example of implementing DBT-CM. Journal of Behavioral Analysis of Offender and Victim Treatment and Prevention, 2(2): 114-23, 2010.

62. Shelton D, Kesten K, Zhang W, Trestman RL. Impact of a Dialectic Behavior Therapy- Corrections Modified upon Behaviorally Challenged Incarcerated Male Adolescents. Journal of Child and Adolescent Psychiatric Nursing. 24: 105-113, 2011

63. Appelbaum K, Savageau J, Trestman RL, Metzner J, Baillargeon JG. A National Survey of Self-Injurious Behavior in American Prisons, Psychiatric Services, 62(3):285-90, 2011.

64. Kesten KL, Leavitt-Smith E, Rau DR, Shelton D, Zhang W, Wagner J, Trestman RL. The Connecticut Offender Re-Entry Program (CORP) and Standard Re-entry Treatment Planning Services: A Comparison of Recidivism Rates Among Mentally Ill Inmates in Connecticut. Journal of Correctional Health Care, 2012, 18(1):20-8. Epub 2011 Nov 17.

65. Kamath J, Zhang W, Kesten K, Wakai S, Shelton D, Trestman RL. Algorithm-Driven Pharmacological Management of Bipolar Disorder in Connecticut Prisons. International Journal of Offender Therapy and Comparative Criminology, 57(2) 251–264 2013, DOI: 10.1177/0306624X11427537, online 24 November 2011.

66. Ehret, M., Shelton, D., Barta, W., Trestman, RL, Maruca, A., Kamath, J., Golay, L. (2013). Medication Adherence Among Female Inmates with Bipolar Disorder: Results from a Randomized Controlled Trial, Psychological Services, 2013, 10(1): 106–114 DOI: 10.1037/a0031433.

16

16

67. Swanson, J., Frisman, L., Robertson, A., Lin, HJ, Trestman RL, et al. Costs of Criminal Justice Involvement among Persons with Serious Mental Illness in Connecticut, Psychiatric Services in Advance, March 15, 2013; doi: 10.1176/appi.ps.002212012.

68. Tanguay S, Trestman RL, Weiskopf C. (2014). Patient Health Satisfaction Survey in Connecticut Correctional Facilities, Journal of Correctional Health Care, Volume 20 Issue 2 April 2014 pp. 127 - 134.

69. Cislo A and Trestman RL. (2012). Challenges and Solutions for Conducting Research in Correctional Settings: The U.S. Experience. International Journal of Law and Psychiatry, 36(3-4), 2013, pp. 304 – 310; DOI: 10.1016/j.ijlp.2013.04.002.

70. Spaulding AC, Kim AY, Harzke AJ, Sullivan JC, Linas BP, Brewer A, Dickert J, McGovern BH, Strick LB, Trestman RL, Ferguson WJ. Impact of New Therapeutics for Hepatitis C Virus Infection in Incarcerated Populations. Topics in Antiviral Medicine, 21(1) 27-35, 2013.

71. Barry LC, Ford JD, Trestman RL. (2014). Comorbid Mental Illness and Poor Physical Function among Newly Admitted Inmates in Connecticut’s Jails. Journal of Correctional Health Care, Volume 20 Issue 2, pp. 135 - 144.

72. Trestman RL, Aseltine RH. Justice-Involved Health Information: Policy and Practice Advances in Connecticut. (2014). Perspectives in Health Information Management. 2014 Winter; 11(Winter): 1e.Published online Jan 1, 2014.

73. Ahalt C, Trestman RL, Rich J, Greifinger R, Williams BA, Paying the Price: The Pressing Need for Quality, Cost and Outcomes Data to Improve Correctional Healthcare for Older Prisoners. Journal of the American Geriatric Society, 61:2013–2019, 2013. DOI: 10.1111/jgs.12510

74. Meyer JP, Cepeda J, Wu J, Trestman RL, Altice, FL, Springer SA. (2014). Optimization of human immunodeficiency virus treatment during incarceration. Viral suppression at the prison gate. JAMA Intern Med. doi:10.1001/jamainternmed.2014.601. Published online March 31, 2014.

75. Trestman, RL. (2014) Ethics, the Law, and Prisoners: Protecting Society, Changing Human Behavior, and Protecting Human Rights, Journal of Bioethical Inquiry, DOI 10.1007/s11673-014-9560-1. Published online July 5, 2014.

76. Trestman R.L., Ferguson W, Dickert J. (2014). Behind Bars: The Compelling Case for of Academic Health Centers Partnering with Correctional Facilities. Academic Medicine, Published online July 24, 2014.

77. Wang EA, Aminawung JA, Ferguson W, Trestman R.L. Wagner EH, Bova C. (2014). A Tool for Tracking Chronic Illness Care in Prison (ACCIC-P). Journal of Correctional Healthcare, 20(4), 313-333.

78. Power J, Trestman RL, Smith H. (2015). What to do with the cutters? Best practices for offender self-injurious behaviors. Criminal Justice Studies. ISSN: 1478-601X (Print) 1478-6028 (Online). http://dx.doi.org/10.1080/1478601X.2015.1112284. Published online November 26, 2015.

79. Angela Di Paola, A., Altice, F.L., Powell, M.L., Trestman, R.L., Springer, S.A. A Comparison of Psychiatric Diagnoses among HIV-Infected Prisoners Receiving Combination Antiretroviral Therapy and Transitioning to the Community. Health and Justice, 764 2014 2:11. http://www.healthandjusticejournal.com/content/2/1/11/email?from=email

80. Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people incarcerated in Connecticut prisons and jail observational cohort study, The Lancet HIV, Early online publication, October 10, 2014, doi: 10.1016/S2352-3018(14)70022-0.

81. Kersten L, Cislo AM, Lynch M, Shea K, Le H, Trestman RL. Evaluating START NOW: A Skills-Based Psychotherapy for Inmates with Behavioral Disorders. Psychiatric Services in Advance (doi: 10.1176/appi.ps.201400471). Published online August 17, 2015.

82. Barry LC, Wakefield DB, Trestman RL, Conwell Y. Active and Passive Suicidal Ideation in Older Inmates. Crisis: The Journal of Crisis Intervention and Suicide Prevention, CRI-MS-1948R1. May 13, 2015.

83. Kamath, J., Wakai, S., Zhang, W., Kesten, K., Shelton, D., Trestman, R.L. Adaptation of the Texas Implementation Medication Algorithm for Bipolar Disorder in Adult Female Offenders: A Quasi-Randomized Study. International Journal of Offender Therapy and Comparative Criminology, 1 – 12, DOI: 10.1177/0306624X15578228. Published online March, 31, 2015.

84. Jillani, S., Patel, P., Kamath, J., Trestman R.L. (2016). Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Incarcerated Adolescents: Literature Review and Case Series. Journal of the American Academy of Psychiatry and the Law, 44:158-163.

85. Michna I, Trestman R.L. (2016). Correctional management and treatment of Autism Spectrum Disorders, Journal of the American Academy of Psychiatry and the Law, 44:253-258.

86. Cislo, A., Trestman R.L. Psychiatric hospitalization after participation in START NOW. Letters to the Editor. Psychiatric Services 2016; 67:143; doi: 10.1176/appi.ps.201500456. Published online January 4, 2016.

17

17

87. Seena Fazel, Adrian J Hayes; Katrina Bartellas; Massimo Clerici; Trestman, R.L. The mental health of prisoners: a review of prevalence, adverse outcomes and interventions. Lancet Psychiatry. Published online July 14, 2016 http://dx.doi.org/10.1016/S2215-0366(16)30142-0.

88. Ferguson W, Cloud D, Taxman FS, Trestman RL, Champion-Lippmann C, Shelton D, Sltice R, Spaulding AC, Thomas D. A Call to Action: A blueprint for Academic Health Sciences in the era of mass incarceration. Journal of Health Care for the Poor and Underserved, 27(2):5-17, 2016.

89. Barry, L., Wakefield, D., Trestman, R.L., Conwell, Y. Disability in Prison Activities of Daily Living and Likelihood of Depression and Suicidal Ideation in Older Inmates. International Journal of Geriatric Psychiatry. Published online September 20 2016, DOI: 10.1002/gps.4578.

90. L Kersten, M Prätzlich, S Mannstadt, K Ackermann, G Kohls, H Oldenhof, D Saure; B Herpertz-Dahlmann; A Popma; C M Freitag; R L Trestman; C Stadler START NOW: Study protocol of a quasi-randomised clinical trial testing a comprehensive skills training for adolescent females with oppositional defiant and conduct disorders, Trials, (2016) 17:568-583; DOI 10.1186/s13063-016-1705-6.

Books:

Trestman RL, Appelbaum KL, Metzner J. (Eds). The Oxford Textbook of Correctional Psychiatry, Oxford University Press, May 2015.

Other Publications: 1. Samejima F and Trestman RL. Analysis of the Iowa data I: Initial findings. Office of Naval Research, Research

Report 80-1, 1980, 156 pp. 2. Stein M and Trestman RL. Anxiety and the immune system. In Neurobiological Basis of Panic Disorder.

Ballinger, J. (ed.), Alan R. Liss Inc., New York. pp. 333-348, 1990. 3. Stein M and Trestman RL. Psychiatric perspectives of brain, behavior and the immune system. In Immunologic

Mechanisms in Neurologic and Psychiatric Disease. Waksman, B. (ed.), ARNMD. Raven Press, New York. pp 161-169, 1990.

4. Stein M, Miller AH and Trestman RL. Depression and the immune system. In Psychoneuroimmunology II. Ader, R., Cohen, N. and Felten, D. (eds.), Academic Press, New York. pp 897-930, 1991.

5. *Trestman, R.L. and Siever, L. The growth hormone response to clonidine in depression. In Biological Markers of Depression: State of the Art. Ansseau M, von Frenckell R and Franck G (eds.), Elsevier, New York. pp 43-53, 1991.

6. O'Brien M, Trestman RL, Siever LJ. Cluster A personality Disorders. In Current Psychiatric Therapy, Dunner DL (ed.), WB Saunders, New York. pp 399-404, 1992.

7. Steinberg BJ, Trestman RL, Siever LJ. The cholinergic and noradrenergic systems and affective instability in borderline personality disorder. In Biological and Neurobehavioral Studies in Borderline Personality Disorder. Silk KR (ed.), American Psychiatric Press, pp 41-62, 1994.

8. deVegvar M, Siever LJ, Trestman RL. Impulsivity and serotonin in borderline personality disorder. In Biological and Neurobehavioral Studies in Borderline Personality Disorder. Silk KR (ed.), American Psychiatric Press, pp 23-40, 1994.

9. Siever LJ, Steinberg B, Trestman RL, Intrator J. Biological markers in personality disorders. Volume 13 Annual Review of Psychiatry 1994 Section II, Gorman J, Papp L (eds.), American Psychiatric Press, pp253-290.

10. *Trestman RL, deVegvar M, Siever LJ. Treatment of personality disorders. Textbook of Psychopharmacology. Nemeroff CB, Schatzberg AF (eds.), American Psychiatric Press, 753-767, 1996.

11. New AS, Trestman RL, Siever LJ. Borderline personality disorder. Impulsivity and Aggression, Hollander E, Stein D (eds), John Wiley & Sons, pp 153-174, 1995.

12. Siever LJ, Trestman RL. The serotonin system and aggressive personality disorders. International Clinical Psychopharmacology Serotonin Supplement, Rapid Communications of Oxford, Ltd, Oxford, 1993, 8:33-39.

13. Amin F, Siever LJ, Silverman JS, Coccaro EF, Mitropoulou V, Trestman RL, Anderson GM, Davis KL. Plasma homovanillic acid in clinically derived schizotypal personality disorder. Plasma Homovanillic Acid Studies in Schizophrenia: Implications for Dopamine Dysfunction, Friedhoff AJ, Amin F (eds.), American Psychiatric Press, Washington DC, 133-149, 1997.

14. Zale, CF, O’Brien MM, Trestman RL, Siever LJ. Cluster A personality disorders. Current Psychiatric Therapy II, Chapter 60, Dunner DL (ed), WB Saunders, pp427-432, 1996.

15. *Trestman RL. Perspectives on Borderline Personality Disorder. The Journal of the California Alliance of the Mentally Ill, 1:10-14, 1997.

16. Porr V and Trestman RL (co-editors). Borderline Personality Disorder. Issue of The Journal of the California Alliance of the Mentally Ill, 1, 1997.

18

18

17. *Trestman RL, Woo-Ming A, deVegvar M, Siever LJ. Treatment of personality disorders. Textbook of Psychopharmacology, 2nd ed. Nemeroff CB, Schatzberg AF (eds.), American Psychiatric Press, pp 901-916, 1998.

18. *Trestman, RL. Behind Bars: Personality Disorders. The Journal of the American Academy of Psychiatry and the Law, 28:232-235, June, 2000.

19. *Trestman, RL. Commentary: Antipsychotic Prescribing Practices in the Texas Prison System. The Journal of the American Academy of Psychiatry and the Law, 29:54-57, 2001.

20. *Trestman, RL, Woo-Ming, A.M., deVegvar, M., Siever, L.J. Treatment of Personality Disorders. Essentials of Clinical Psychopharmacology, Schatzberg AF, Nemeroff CB (eds.), American Psychiatric Press, pp 571-587, 2001.

21. Rayford, B. & *Trestman, RL. The Intensive Mental Health Unit in Connecticut’s Department of Correction: A Model Treatment Program. Psychiatric Times, March 2002.

22. *Trestman, RL. Commentary: Problems in Correctional psychiatry. Journal of the American Academy of Psychiatry & The Law, 30:30-2, 2002

23. *Trestman, RL & Macura, T. Psychopharmacological Research in Corrections: A Needs Assessment. Psychiatric Times’ Mental Health Outcomes, pp 1-3, June, 2002.

24. Champion M, Trestman RL. Interface Between Department of Mental Health and the Department of Correction. American Academy of Psychiatry & Law Newsletter, September, 2002

25. Huey, LH, Cole, S., Trestman, RL, Tinsley, JA. Managed Behavioral Healthcare and Healthcare Reform. In: The Comprehensive Textbook of Psychiatry, 8th Edition, B.J. Sadock, V.A. Sadock, Eds., 2004

26. *Trestman RL. Combined Psychotherapy and Psychopharmacology for Treating Patients with Severe Personality Disorder. Psychiatric Times, pp 35-38, October 2004.

27. Leebens PK, Trestman RL, Prozac for preteens: Antidepressants can help. New Haven Register, Opinion Forum, December 5, 2004

28. Buscema C, Trestman RL. Treatment Algorithms: The Correctional Setting. American Academy of Psychiatry and the Law Newsletter, 19-20, January 2005

29. Trestman RL, Candilis P, Silberberg J, Temporini H. Correctional Mental Health Research. American Academy of Psychiatry and the Law Newsletter, pp 10-11, April 2005

30. Trestman RL. An Academic- Correctional Partnership- Connecticut’s Development of Correctional Mental Health Services Research. Corrections Today, pp 42-44, July 2006.

31. Sampl, S., Trestman, R.L. START NOW: A Comprehensive Coping Skills Training Program for Offenders. http://cmhc.uchc.edu/programs_services/startnow.aspx, (2006).

32. Trestman RL. Research with Prisoners.(Chapter 20) In: Correctional Psychiatry, M. Piasecki and O. Theinhaus, Eds. Civic Research Institute, Kingston NJ, pp 20.1 – 20.10, 2007

33. Trestman RL. Current Pragmatics of Prisoner Research, Commissioned Paper in support of the Institute of Medicine’s Committee on Ethical Considerations for Revisions to DHHS Regulations on Prisoner Research, 2006

34. de Ruiter C, Trestman RL. Prevalence and Treatment of Personality Disorders in Dutch Forensic Mental Health Services, Journal of the American Academy of Psychiatry and the Law, 35(1):92-7, 2007

35. Trestman RL. Sherwin Nuland MD: Physician Assisted Suicide. American Academy of Psychiatry and Law Newsletter, Vol 32(1), pp 12-13, 2007

36. Trestman RL, Eucker S, Müller-Isberner R. The Treatment of Personality Disordered Offenders in Germany, Journal of the American Academy of Psychiatry & The Law, 35(2): 229-34, 2007

37. Wakai S, Trestman RL. Impulsivity and Aggression. In: Textbook of Violence Assessment and Management, R. Simon and K. Tardiff, Eds. Arlington, VA: APPI, pp 211-234, 2008.

38. Ford J, Trestman RL. Evidence Based Enhancement of the Detection, Prevention, and Treatment of Mental Illness in the Correction Systems,” August 2005, NCJ 210829, available online at www.ncjrs.org/ pdffiles1/nij/grants/ 210829.pdf

39. Ford J, Trestman RL, Osher F, Scott JE, Steadman HJ, Robbins PC. Mental Health Screens for Corrections. May 2007, NCJ 216152, available online at http://www.ojp.usdoj.gov/nij/pubs-sum/216152.htm.

40. Wortzel H, Trestman RL. Forensic Neuropsychiatry. In: Textbook of Neuropsychiatry and Behavioral Neurology, Chirstopher Filley, David Arciniegas, and C. Alan Anderson, Eds. Cambridge University Press, pp 406-414, 2013.

41. Helfand SJ, Sampl S, Trestman RL. Managing the Disruptive/Aggressive Inmate, In: Handbook of Correctional Mental Health, 2nd Edition, Charles Scott, Ed. APPI, pp197-230, 2009.

42. Trestman RL, Lazrove S. On the Coming of Age of Antisocial Personality Disorder: A Commentary on the NICE Treatment Guidelines for Antisocial Personality Disorder. Personality and Mental Health, 4:12-15, 2010.

43. Harlow MC, Trestman RL. The Professional Imperative and Challenges of Psychiatry Research. American Academy of Psychiatry and Law Newsletter, Vol 34(3), p20, 2009.

44. Trestman RL. Evidence Based Practice Can Transform Care. Guest Editorial in NCCHC CorrectCare, 24(3):3, 2010.

19

19

45. Sampl S, Trestman RL, START NOW Facilitator Manual, Version 2.1, June 3, 2010. http://cmhc.uchc.edu/programs_services/startnow.aspx

46. Sampl S, Trestman RL, Harrison J. START NOW Workbook for Female Participants, Version 2.1, July 16, 2010. http://cmhc.uchc.edu/programs_services/startnow.aspx

47. Sampl S, Trestman RL, START NOW Workbook for Male Participants, Version 2.1, July 16, 2010. http://cmhc.uchc.edu/programs_services/startnow.aspx

48. Trestman RL, Shelton D. Final Report: Mental Health Subscale Development for the National Survey of Prison and Jail Inmates, Bureau of Justice Statistics, June 2010

49. Trestman RL, Bradford JMW, Scott CL. The 2011 AAPL Research Survey and the AAPL/AP-LS Forensic Research Collaborative. AAPL Newsletter, 37(1):21-30, 2012.

50. Trestman RL, Barry L. Implications of Clinical Assessment for Reentry Planning and Community-Based Treatment, in Dlugacz HA (Ed.) Re-Entry Planning for Offenders with Mental Disorders: Policy and Practice, Civic Research Institute, Kingston NJ. Vol II (2), pp 2-1 - 2-11, 2015.

51. Trestman RL. Book Review of Cohen, F., Knoll, J.L., Kupers, T.A., Metzner, J.L. Practical Guide to Correctional Mental Health and the Law. Kingston, NJ: Civic Research Institute, 2011. In PSYCHIATRIC TIMES, 29(6):33, 2012

52. Berger, R., Chaplin, M. Paul, Trestman, RL. Commentary. Toward an Improved Understanding of Administrative Segregation: What are we trying to achieve? The Journal of the American Academy of Psychiatry and the Law, 41:61-64, 2013.

53. Singh, J. P., Yang, S., Bjorkly, S., Boccacini, M. T., Borum, R., Buchanan, A., Cooke, D., de Ruiter, C., Desmarais, S. L., Douglas, K. S., Doyle, M., Edens, J. F., Elbogen, E. B., Endrass, J., Fazel, S., Grann, M., Guy, L. S., Hanson, R. K., Hare, R. D., Harris, G. T., Hart, S. D., Heilbrun, K., Larsen, M. A., Monahan, J., Montaldi, D. F., Mossman, D., Nicholls, T. L., Ogloff, J. R. P., Otto, R. K., Petrila, J., Pham, T. H., Rettenberger, M., Rice, M., Rossegger, A., Scurich, N., Skeem, J. L., Trestman, R. L., Urbaniok, F., Viljoen, J. L., & Mulvey, E. (2013). Reporting standards for risk assessment predictive validity studies: The Risk Assessment Guidelines for the Evaluation of Efficacy (RAGEE) Statement. Tampa, FL: University of South Florida.

54. Trestman RL, Clinical Implications of Working with Patients on Parole or Probation. Psychiatric Times August 14, 2013, http://www.psychiatrictimes.com/clinical-implications-working-patients-parole-or-probation#sthash.67aj9O9h.dpuf

55. Metzner JL, Appelbaum KL, Trestman RL. Correctional Psychiatry and the Forensic Psychiatrist In: Robert Sadoff MD (Ed.): "Forensic Psychiatry: History, Current Developments, Future Directions". New York: Oxford University Press, pp.173-180, 2016.

56. Trestman RL, Wall AT. Interdiction of Drugs in Correctional Settings, in Rich J, Kinner S (Eds), Drug Abuse in Jails and Prisons, In press.

57. Trestman RL, Volkmar F, Gold LH. Accessing Mental Health Treatment, in Liza H Gold MD and Robert I Simon MD (eds), Gun Violence and Mental Illness (American Psychiatric Publishing, Inc.), 2015, pp 185-217.

58. Trestman RL (Work Group Chair), American Psychiatric Association, Psychiatric Services in Correctional Facilities, 3rd ed. American Psychiatric Press, July 2015.

59. Downer AV, Trestman RL. The Prison Rape Elimination Act and Correctional Psychiatrists. Editorial, Journal of the American Academy of Psychiatry and the Law, 44:9-13. March 2016.

60. Creuzot, J, D’Amora, D, Dvoskin, J, Goss, S,Hart, S, Heilbrun, K, Leifman, S, Monahan, J, Osher, F, Pinals, D, Primm, A, Rotter, M, Schmucker, C, Steadman, H, Trestman, RL, VanNostrand, M. On the Over-Valuation of Risk for People with Mental Illnesses, The Council of State Governments Justice Center Consensus Statement, American Psychiatric Association Foundation, https://csgjusticecenter.org/wp-content/uploads/2016/03/JC_MH-Consensus-Statements.pdf , Fall 2015.

61. Trestman, RL. START NOW: Psychotherapy in Prison. Connecticut Psychiatrist, A Publication of the Connecticut Psychiatric Society, 55:1-9, April 2016.

62. Kapoor R, Trestman RL. Mental Health Effects of Restrictive Housing. Chapter 6, In Marie Garcia (Ed), “Restrictive Housing in the U.S. Issues, Challenges, and Future Directions,” pp 199-232. NCJ 250315, 2016. Available at https://www.ncjrs.gov/pdffiles1/nij/250315.pdf

63. Krauss W, Sampl S, Scudder M, Wright JA, Houde A, Haga J, Trestman RL. Development and Implementation of START NOW within a Correctional System, 2016, Accessible at: http://cmhc.uchc.edu/pdfs/startnow/Publications/START%20NOW%20Development%20and%20Implementation%20Article.pdf

64. Trestman RL, Baskin-Somers A. Research in Corrections, In Gold L, Frierson R, Textbook of Forensic Psychiatry, American Psychiatric Press, In Press.

20

20

65. Trestman RL, Applebaum KL, Metzner JL. Clinical Treatment in Corrections, In Gold L, Frierson R, Textbook of Forensic Psychiatry, American Psychiatric Press, In Press.

66. Metzner JL, Trestman RL, Hurt BL, Hamilton JP. Alternatives to long-term solitary confinement. Correctional Law Reporter, 28:39-51, 2016.

67. Trestman RL. Commentary: Applying a Positive Behavioral Approach to Treating Aggression in Forensic Psychiatric Settings, Journal of the American Academy of Psychiatry and the Law, 45:40-43, 2017.

ABSTRACTS: 1. Dismuke, S.E., McClary, A., Trestman, RL, Lassiter, D. and Dickson, H. Physician attitudes and action in

preventive medicine. Clinical Research, 32(5): A922, 1984. 2. Coccaro, E.F., Siever, L.J., Kavoussi, R., Trestman, RL, Howard, L., and Davis, K.L. Serotonergic correlates of

personality disorder. American Psychiatric Association Annual Meeting, (poster presentation), May, 1988. 3. Halper, J.P., Miller, A.H., Lackner, C., Trestman, B., Berkenbosch, F., Santucci, A, Haroutunian, V. and Stein, M.

Effect of brief stressors on lymphocyte function in rats: Mechanistic implications. Society for Neuroscience Abstracts, 15: A119.16, (poster presentation) 1989.

4. *Trestman, R., Teicher, M., Coccaro, E., Bernstein, D., Gabriel, S., Knott, P., and Siever, L. Disruption of noradrenergic and neuroendocrine rhythms in depression. Society of Biological Psychiatry Annual Meeting, (oral presentation) May, 1990.

5. *Trestman, RL, Coccaro, E., Bernstein, D., Lawrence, T., Horvath, T., and Siever, L.J. Norepinephrine and cortisol responses to naturalistic stressors in acute and remitted depression. Society of Biological Psychiatry Annual Meeting, (poster presentation) May, 1990.

6. *Trestman, RL, Teicher, M., Coccaro, E., Bernstein, D., Gabriel, S., and Siever, L. Noradrenergic/ HPA dysregulation in depression. American Psychiatric Association Annual Meeting, May, 1990 (poster presentation).

7. Levine, S.M., Trestman, RL, Cunningham-Rundles, C., and Halper, J. Catecholamine levels in Chronic Fatigue Syndrome. American Psychiatric Association Annual Meeting, May, 1990 (poster presentation).

8. Siever, L.J., Trestman, RL, Coccaro, E.F., Bernstein, D., Gabriel, S.M., Owen, K., Moran, M., Lawrence, T., Rosenthal, J., and Horvath, T.B. Clinical applications of the clonidine test: The growth hormone response to clonidine in depression and personality disorders. International Congress: Biological Markers of Depression: State of the Art, (abstract book) June, 1990.

9. Siever LJ, Coccaro EF, Lawrence TL, Trestman RL, Gabriel S, Knott P, Silverman J. Serotonergic-catecholaminergic interactions in the affective and personality disorders. American College of Neuropsychopharmacology Annual Meeting, (poster presentation), December, 1990.

10. Mahon T, Kalus O, Trestman RL, Mitropoulou V, Weisberg J, Gruber L, Gabriel S, Siever L. Growth hormone coefficient of variation in personality disorders. Society of Biological Psychiatry Annual Meeting, May, 1991.

11. Rotter M, Kalus O, Losonczy M, Guo L, Trestman RL, Coccaro E, Davidson M, Davis K, and Siever L. Lateral ventricle enlargement in schizotypal personality disorder. Society of Biological Psychiatry Annual Meeting, May 1991.

12. *Trestman RL, Lawrence TL, Coccaro EF, Mitropoulou V, Gabriel S, Weston S, and Siever LJ. Impulsivity, aggression and prolactin response to fenfluramine in personality disorders. Paper presented at Society of Biological Psychiatry Annual Meeting, Abstract #115, May 1991.

13. *Trestman RL, Teicher MH, Coccaro EF, Harper D, Mitropoulou V, Gabriel S, Knott P, and Siever LJ. Non-linear multioscillator analyses of noradrenergic and neuroendocrine regulation in depression. Paper presented at Society of Biological Psychiatry Annual Meeting, Abstract #26, May 1991.

14. Lawrence T, Coccaro EF, Trestman RL, Bernstein D, Mitropoulou V, and Siever L. Noradrenergic function as a correlate of impulsive/ aggressive behavior in personality disorder. Society of Biological Psychiatry Annual Meeting, May 1991.

15. Rotter M, Kalus O, Losonczy M, Guo L, Trestman RL, Coccaro E, Davidson M, Davis K, and Siever L. Enlarged VBR in schizotypal personality disorder. American Psychiatric Association Annual Meeting, May, May 1991.

16. Amin F, Coccaro EF, Trestman RL, Knott P, Mahon T, Davidson M, Davis KL, and Siever LJ. CSF HVA in schizotypal and other PDs. American Psychiatric Association Annual Meeting, May 1991.

17. Lawrence T, Coccaro E, Trestman RL, Bernstein D, Mitropoulou V, and Siever L. Noradrenergic activity in impulsivity/ aggression. American Psychiatric Association Annual Meeting, May 1991.

18. Kalus O, Keefe R, Lees S, Moskowitz J, Trestman RL, Harvey P, Porter C, and Siever L. Prefrontal lobe function in schizotypal personality disorder. Society of Biological Psychiatry Annual Meeting, May 1991.

19. *Trestman RL, Teicher M, Coccaro EF, Harper D, Mahon T, Mitropoulou V, and Siever LJ. Disturbed neuroendocrine regulation in depression. American Psychiatric Association Annual Meeting, Abstract #71, May 1991.

21

21

20. *Trestman RL, Lawrence TL, Coccaro EF, Mitropoulou V, Weston S, Weisberg J, Gabriel S, Siever LJ. Impulsivity and 5HT in personality disorders. American Psychiatric Association Annual Meeting, Abstract #167, May 1991.

21. Siever LJ, Maurer G, Trestman RL, Weisberg J, Kalus O, and Coccaro E. Anhedonia and schizophrenia spectrum disorders. American Psychiatric Association Annual Meeting, (Symposium presentation), May 1991.

22. *Trestman RL, Lawrence TL, Coccaro EF, Mitropoulou V, Gabriel S, Weston S, and Siever LJ. Impulsivity, aggression and prolactin response to fenfluramine in personality disorders. Neuroendocrinology Letters, 13:192, 1991.

23. *Trestman RL, Teicher MH, Coccaro EF, Harper D, Mitropoulou V, Gabriel S, Knott P, and Siever LJ. Non-linear multioscillator analyses of noradrenergic and neuroendocrine regulation in depression. Neuroendocrinology Letters, 13:237, 1991.

24. Siever LJ, Coccaro EF, Lawrence TL, Trestman RL, Gabriel S, Knott P, Silverman J. Serotonergic-catecholaminergic interactions in the affective and personality disorders. Proc 29th Annual Meeting, American College Neuropsychopharmacology, 1990.

25. Amin F, Siever LJ, Silverman J, Trestman RL, Knott P, Davidson M, Davis KL. Dopaminergic dysfunction in schizotypal personality disorder. Proc 30th Annual Meeting, American College of Neuropsychopharmacology, 1991.

26. Siever LJ, Trestman RL, Coccaro EF, Teicher M, Lawrence T, Silverman J. The noradrenergic system in the affective and personality disorders. Proc 30th Annual Meeting, American College of Neuropsychopharmacology, 1991.

27. *Trestman RL, Coccaro EF, Mitropoulou V, Weston S, Ramella F, Siever LJ. Arousal and impulsivity in the personality disorders: Differential correlates with central noradrenergic and serotonergic function. Proc 30th Annual Meeting, American College of Neuropsychopharmacology, 1991.

28. *Robert L. Trestman PhD MD, Emil F. Coccaro MD, Susan Weston MD, Vivian Mitropoulou MA, Felice Ramella BA, Steven Gabriel PhD, Larry J. Siever MD. Impulsivity, suicidal behavior and major depression in the personality disorders: differential correlates with noradrenergic and serotonergic function. Biological Psychiatry, 31:68a, 1992.

29. F Amin, L Siever, RL Trestman, J Silverman, O Kalus, M Rotter P Knott, G Anderson, KL Davis. Dopamine system in schizotypal personality disorder. Biological Psychiatry, 31:163a, 1992.

30. Julia K. Temple, Robert L. Trestman, Emil F. Coccaro, Vivian Mitropoulou, Felice Ramella, Steven Gabriel, Larry J. Siever. State dependent cortisol response to clonidine in acute and remitted depression. Biological Psychiatry, 31:134a, 1992.

31. Myron Weiner, Moinuddin Muttakin, Richard Risser, Robert L. Trestman. Cortisol secretion in late-life depressives. Biological Psychiatry, 31:100a, 1992.

32. Rene S. Kahn, Robert L. Trestman, Brian Lawlor, Jason Gold, Larry Siever, Michael Davidson. Ipsapirone as a probe for 5-HT1a receptors: A dose-response study in healthy subjects. Biological Psychiatry, 31:104a, 1992.

33. *Robert L. Trestman PhD MD, Emil F. Coccaro MD, Julia Temple MD, Felice Ramella BA, Steven Gabriel PhD, Larry J. Siever MD. Impulsivity and serotonin in borderline PD. Proc American Psychiatric Association Annual Meeting, Paper 50C, p 194, 1992.

34. Siever LJ, Trestman RL, Weston S, Lawrence T, Knott P, Coccaro E. Noradrenergic/ cholinergic function in borderline PD. Proc American Psychiatric Association Annual Meeting, Paper 50D, p 194-195, 1992.

35. *Robert L. Trestman PhD MD, Emil F. Coccaro MD, Susan Weston MD, Vivian Mitropoulou MA, Felice Ramella BA, Steven Gabriel PhD, Larry J. Siever MD. Biology of impulsivity, suicide and MDD in Axis II. Proc American Psychiatric Association Annual Meeting, Abstract #NR-85, 1992.

36. Julia K. Temple, Robert L. Trestman, Emil F. Coccaro, Vivian Mitropoulou, Felice Ramella, Steven Gabriel, Larry J. Siever. MDD State dependent cortisol response to clonidine. Proc American Psychiatric Association Annual Meeting, Abstract #NR-109, 1992.

37. F Amin, L Siever, RL Trestman, J Silverman, O Kalus, M Rotter P Knott, G Anderson, KL Davis. Dopamine system in schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, Abstract #NR-84, 1992.

38. LJ Siever, RL Trestman, TL Lawrence, EF Coccaro, V Mitropoulou, S Gabriel, P. Knott, S. Weston. Neuroendocrine aspects of borderline personality disorder. Neuroendocrinology Letters, 13:134, 1991.

39. Larry J. Siever, Robert L. Trestman, Julia Temple. Psychoneuroendocrinologic correlates of personality disorders. Proc XXIII Congress of the ISPNE, p 85, 1992.

40. *Robert L. Trestman, Emil F. Coccaro, Vivian Mitropoulou, Felice Ramella, Steven Gabriel, Larry J. Siever. Differential biology of impulsivity, suicide and depression in personality disorders. Proc XXIII Congress of the ISPNE, p 92, 1992.

41. Larry Siever, Robert Trestman, Emil Coccaro, Marie deVegvar, Susan Weston, Bonnie Steinberg, Steven Gabriel, Peter Knott, Jeremy Silverman. Neurochemical correlates of impulsive, affective and cognitive symptoms in borderline personality disorder. Proc 31st Ann Mtg, American College of Neuropsychopharmacology, p 24, 1992.

22

22

42. *Robert Trestman, Emil Coccaro, Vivian Mitropoulou, David Gold, Orna Guralnik, Steven Gabriel, Larry Siever. Impulsivity, suicide and depression: Differential biology in personality disorders. Proc 31st Annual Meeting, American College of Neuropsychopharmacology, p 91, 1992.

43. Farooq Amin, Larry J. Siever, Jeremy Silverman, Robert Trestman, Peter Knott, Michael Davidson. Dopamine metabolism in schizotypal personality disorders. Proc 31st Annual Meeting, American College of Neuropsychopharmacology, p 117, 1992.

44. Rachel Yehuda, Robert Levengood, Robert Trestman, Martin Teicher, Karen Binder-Brynes, Ilana Schlein, Douglas Gerber, Frank Mereweather, Jennifer Geni, Larry Siever. Circadian rhythms of cortisol in posttraumatic stress disorder. Proc 31st Annual Meeting, American College of Neuropsychopharmacology, p 158, 1992.

45. Emil F. Coccaro, Richard J. Kavoussi, Robert L. Trestman, Larry J. Siever. Serotonin and impulsive aggression: Significance of simultaneous assessment of pre- and post-synaptic indices of serotonin function. Proc 31st Annual Meeting, American College of Neuropsychopharmacology, p 197, 1992.

46. Rene Kahn, Robert Trestman, Larry Siever, Michael Davidson, Robert Weitzner. Ipsapirone as a probe for 5HT1a receptors. Proc 31st Annual Meeting, American College of Neuropsychopharmacology, p 191, 1992.

47. LJ Siever, EF Coccaro, RL Trestman, S. Gabriel. The serotonin system and aggressive personality disorders. Proc Advances in the Pharmacology and Clinical Applications of Serotonin, 1993.

48. Joanne Intrator, RL Trestman, Vivian Mitropoulou, Irene Lopez, Eyal Pavell, Elena Taurke, Larry J. Siever. Clinical dimensions of the dramatic cluster: Self report and biological validators. Biological Psychiatry, 33:85A, 1993.

49. Bonnie Steinberg, Susan Weston, Robert L. Trestman, Virginia Condello, Julia Temple, Damon Mitchell, Larry J. Siever. Affective instability in personality disordered patient’s correlates with mood response to physostigmine challenge. Biological Psychiatry, 33:86A, 1993.

50. EF Coccaro, RJ Kavoussi, RL Trestman, LJ Siever. 5-HT and aggression: Assessment of pre- and post-synaptic indices of 5-HT. Biological Psychiatry, 33:87A, 1993.

51. *Robert L. Trestman, Marie deVegvar, Emil F. Coccaro, Vivian Mitropoulou, Irene Lopez, Steven Gabriel, Larry J Siever. The differential biology of impulsivity, suicide, and aggression in depression and in personality disorders. Biological Psychiatry, 33:46A-47A, 1993.

52. Marie-Louise deVegvar, Richard Keefe, Jackie Moskowitz, Sonia Lees, Oren Kalus, Peter Knott, Robert L. Trestman, Larry J. Siever. Performance on tests sensitive to frontal lobe dysfunction and "deficit-like" symptoms in schizotypal personality disorder. Biological Psychiatry, 33:101A, 1993.

53. Larry J. Siever, Robert L. Trestman, Emil F. Coccaro, Marie deVegvar, Steven Gabriel. Serotonin and impulsivity. Proc American Psychiatric Association Annual Meeting, Paper 10B, p 130-131, 1993.

54. Rachel Yehuda, Earl Giller, Robert Levengood, Robert L. Trestman, Martin H. Teicher. Enhanced sensitivity of HPA axis in combat PTSD. Proc American Psychiatric Association Annual Meeting, Paper 51C, p 188, 1993.

55. Larry J. Siever, Robert L. Trestman, Emil F. Coccaro, Marie deVegvar, Steven Gabriel, Jeremy Silverman. Challenge tests in the personality disorders. Proc American Psychiatric Assn Annual Mtg, 100E, p 257, 1993.

56. Bonnie J. Steinberg, Susan Weston, Robert L. Trestman, Julia Temple, Damon Mitchell, Larry Siever. Mood response to cholinergics in personality disorder patients. Proc American Psychiatric Association Annual Meeting, NR113, p 88, 1993.

57. Rachel Yehuda, Robert Levengood, Martin Teicher, Robert L. Trestman, Karen Binder-Byrnes, Ilana Schlein, Larry Siever. Circadian release of cortisol in combat PTSD. Proc American Psychiatric Association Annual Meeting, NR225, p 116, 1993.

58. *Robert L. Trestman, Marie deVegvar, Emil Coccaro, Vivian Mitropoulou, Irene Lopez, Steven Gabriel, Larry Siever. Differential biology of aggression and suicide. Proc American Psychiatric Association Annual Meeting, NR439, p 169, 1993.

59. Joanne Intrator, Robert L. Trestman, Vivian Mitropoulou, Irene Lopez, Eyal Pavell, Elena Taurke, Larry Siever. The dramatic cluster dimensions and validators. Proc American Psychiatric Association Annual Meeting, NR334, p 143, 1993.

60. Larry J. Siever, Merrill Rotter, Robert L. Trestman, Emil F. Coccaro, Miklos Losonczy, Kenneth Davis. Increased ventricular brain ratio in schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, NR335, p 143, 1993.

61. Marie-Louise deVegvar, Richard Keefe, Jackie Moskowitz, Sonia Lees, Oren Kalus, Peter Knott, Robert L. Trestman, Larry J. Siever. Frontal lobe dysfunction and schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, NR502, p 186, 1993.

62. Milton Wainberg, Robert L. Trestman, Richard Keefe, Barbara Cornblatt, Marie-Louise deVegvar, Larry Siever. Continous performance test in schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, NR501, p 186, 1993.

23

23

63. Siever LJ, Coccaro EF, Trestman RL, Gabriel S. Use of serotonin-active agents in other psychiatric disorders. Clin-Neuropsychopharmacology, 15(S1), p355A-356A, 1992.

64. Siever LJ, Trestman RL, Coccaro EF, Amin, Lawrence T, Gabriel S, Mitropoulou V. Monoamines in personality disorder. Clin-Neuropsychopharmacology, 15(S1), p231A-232A, 1992.

65. *Robert L. Trestman, Marie deVegvar, Emil Coccaro, Vivian Mitropoulou, Irene Lopez, Steven Gabriel, Larry Siever. Differential biology of aggression and suicide. Proc Third Congress International Society for the Study of Personality Disorders, 1993.

66. Joanne Intrator, Robert L. Trestman, Vivian Mitropoulou, Irene Lopez, Eyal Pavell, Elena Taurke, Larry Siever. The dramatic cluster dimensions and validators. Proc Third Congress International Society for the Study of Personality Disorders, 1993.

67. Marie-Louise deVegvar, Richard Keefe, Jackie Moskowitz, Sonia Lees, Oren Kalus, Peter Knott, Robert L. Trestman, Larry J. Siever. Frontal lobe dysfunction and schizotypal personality disorder. Proc Third Congress International Society for the Study of Personality Disorders, 1993.

68. Milton Wainberg, Robert L. Trestman, Richard Keefe, Barbara Cornblatt, Marie-Louise deVegvar, Larry Siever. Continous performance test in schizotypal personality disorder. Proc Third Congress International Society for the Study of Personality Disorders, 1993.

69. *Robert L. Trestman. Dopaminergic challenge strategies in personality disorders. Symposium Presentation. Proc Third Congress International Society for the Study of Personality Disorders, 1993.

70. Larry J. Siever, Robert L. Trestman, Emil Coccaro, Marie deVegvar, Steven Gabriel. Serotonin and Impulsivity. Proc American Psychiatric Association Annual Meeting, Symposium 10, p 40, 1993.

71. Larry Siever, Robert L. Trestman, Emil Coccaro, Marie deVegvar, Steven Gabriel, Jeremy Silverman. Challenge tests in the personality disorders. Proc American Psychiatric Assn Annual Meeting, Symposium 100, p 125, 1993.

72. *Robert L Trestman, Marie deVegvar, Emil Coccaro, Larry J Siever. Depression and personality disorder: differential biology of aggression and suicide. Neuroendocrinology Letters, 15:353, 1993.

73. *RL Trestman, M Losonczy, B Siegel, M Buchsbaum, E Pavell, LJ Siever. Functional imaging with SPECT of cognitive activity in schizotypal personality disorder. Society for Neuroscience Abstracts, 23rd Annual Meeting, Washington DC, #769.8, p1885, November, 1993.

74. Larry Siever, Leonard Handelsman, Jeffrey Halperin, Jeffrey Newcorn, Vansh Sharma, Emil Coccaro, David Bernstein, Karen Holloway, Robert Trestman. Impulsivity, attention deficit disorder, and substance abuse: The neuropsychopharmacologic link. Proc American College of Neuropsychopharmacology, 32nd Annual Meeting, p30, Dec 13-17, 1993.

75. Larry J Siever, Robert L Trestman, Farooq Amin, Richard SE Keefe, Phil Harvey, Richard Mohs, Kenneth Davis. Dopamine and cognition in schizotypal personality disorder. Proc American College of Neuropsychopharmacology, 32nd Annual Meeting, p51, Dec 13-17, 1993.

76. Monte S. Buchsbaum, Robert L Trestman, Nancy C. Andreasen, Lucy Brown, Harold A. Sackheim, Karen F. Berman. Functional imaging of cognitive challenges in the schizophrenias. Proc American College of Neuropsychopharmacology, 32nd Annual Meeting, p42, Dec 13-17, 1993.

77. *Robert L Trestman, Antonia New, Joel Gelernter, Marie deVegvar, Joseph Erdos, Vivian Mitropoulou, Larry Siever. Biology of self-injurious behavior, aggression, and suicide in MDD and personality disorder. Proc American College of Neuropsychopharmacology, 32nd Annual Meeting, p161, Dec 13-17, 1993.

78. *Robert Trestman, Leonard Handler, Howard Pollio. Anxiety indices in figure drawings of cancer patients. Proc Society for Personality Assessment, Annual Meeting, p10, April 14-17, 1994.

79. *RL Trestman, M Buchsbaum, B Siegel, M Losonczy, C Shaefer, LJ Siever. Functional imaging with SPECT of cognitive activity in schizotypals. Biological Psychiatry, 35:152A, 1994.

80. *RL Trestman, M Buchsbaum, B Siegel, M Losonczy, C Shaefer, LJ Siever. SPECT imaging of cognition activity in schizotypals. Proc American Psychiatric Association Annual Meeting, NR381, p156, 1994.

81. Steinberg BJ, Trestman RL, Mitropoulou V, Coccaro E, Siever LJ. Diurnal MHPG, cortisol, and autonomic rhythms in acute and remitted depression. Biological Psychiatry, 35:196A, 1994.

82. Steinberg BJ, Trestman RL, Lopez I, Pavell E, Siever LJ. Cholinergic challenge and affective instability in personality disorder patients. Biological Psychiatry, 35:452A, 1994.

83. New A, Trestman RL, Siever LJ. Serotonin and self-directed aggression in personality disorders. Biological Psychiatry, 35:112A, 1994.

84. New A, Trestman RL, Kano M, Gettinger S, Siever LJ. Serum cholesterol and impulsivity in mood and personality disorders. Biological Psychiatry, 35:451A, 1994.

85. Bergman A, Mitropoulou V, Trestman RL, Siever LJ. Factor structure of schizotypy. Biol Psychi, 35:453A, 1994. 86. Handelsman L, Bernstein D, Holloway K, Sheikh I, Trestman RL, Siever LJ, Cooper T. Hostile/impulsive traits in

addicts: 5-HT behavioral pharmacology. Biological Psychiatry, 35:37A, 1994.

24

24

87. Steinberg BJ, Trestman RL, Mitropoulou V, Coccaro E, Siever LJ. Diurnal MHPG, cortisol, and autonomic rhythms in acute and remitted depression. Proc American Psychiatric Association Annual Meeting, NR191, p105, 1994.

88. Steinberg BJ, Trestman RL, Lopez I, Pavell E, Siever LJ. Cholinergic challenge and affective instability in personality disorder patients. Proc American Psychiatric Association Annual Meeting, NR378, p155, 1994.

89. New A, Trestman RL, Siever LJ. Serotonin, self-injury and suicide in personality disorders. Proc American Psychiatric Association Annual Meeting, 88E, p161, 1994.

90. New A, Trestman RL, Kano M, Gettinger S, Siever LJ. Serum cholesterol and impulsivity in mood and personality disorders. Proc American Psychiatric Association Annual Meeting, NR379, p155, 1994.

91. Bergman A, Mitropoulou V, Trestman RL, Siever LJ. The factor structure of schizotypy. Proc American Psychiatric Association Annual Meeting, NR380, p156, 1994.

92. Siever LJ, Steinberg BJ, Trestman RL, Intrator J. Personality Disorders. Proc American Psychiatric Assn Ann Meeting, p342, 1994.

93. *Trestman RL, Steinberg BJ, Mitropoulou V, New A, Lopez I, Siever LJ. Differential biological mediation of affective instability and behavioral impulsivity in personality disorders. Proc 25th Congress Intl Soc Psychoneuro-endocrinology, p47, 1994.

94. deVegvar M, Trestman RL, Lawrence TL, Coccaro EF: Impulsivity and 5-HT in personality disorders. The Mount Sinai Journal of Medicine, p 6, November, 1994.

95. Weston S, Trestman RL, Lawrence TL, Coccaro EF: Noradrenergic function as a correlate of impulsive-aggressive behavior in personality disorder. The Mount Sinai Journal of Medicine, p 6, November, 1994.

96. *Trestman RL, Teicher MH, Cocaro EF, Harper, D: Nonlinear multioscillator analyses of noradrenergic and neuroendocrine regulation in depression. The Mount Sinai Journal of Medicine, p 7, November, 1994.

97. Weston S, Trestman RL, Temple J, Coccaro EF: Cortisol response to clonidine in acute and remitted male depressed patients: evidence for a state-dependent relationship. The Mount Sinai Journal of Med, p7, Nov 1994.

98. Yehuda R, Levengood R, Teicher M, Trestman RL, Siever LJ: Circadian release of cortisol in combat veterans with post-traumatic stress disorder (PTSD). The Mount Sinai Journal of Medicine, p 7, November, 1994.

99. Wainberg M, Trestman RL, Keefe RSE, Cornblatt B: Neurocognitive functioning in schizotypal personality disorder: the continuous performance test. The Mount Sinai Journal of Medicine, p 8, November, 1994.

100. Steinberg B, Weston S, Trestman RL, Temple J, Mitchell D, Gold D, Gurainik, Siever LJ: Physostigmine challenge in affectively unstable personality disorder patients. The Mount Sinai Journal of Medicine, p 8, November, 1994.

101. *Trestman RL, deVegvar M, Coccaro EF, Mitropoulou V, Lopez I, Gabiel S, Siever LJ: Aggression and suicide in personality disorder (PD) and major depressive disorder (MDD): differential biology. The Mount Sinai Journal of Medicine, p 9, November, 1994

102. Siever LJ, Trestman RL, Silverman J, Erdos J, Gelernter J. Impulsivity and tryptophan hydroxylase allelic status in personality disordered patients. Proc American College of Neuropsychopharmacology, p17, 1994.

103. Yehuda R, Resnick H, Pitman R, Foy D, Trestman R, Steinberg B, Siever LJ. Enhanced neurobiological sensitization following trauma. Proc American College of Neuropsychopharmacology, p53, 1994.

104. *Trestman RL, Siegel B, Losonczy M, Mitropoulou V, Silverman J, Keefe R, Mohs R, Buchsbaum M, Davis KL, Siever LJ. Neuroimaging, neurobiological, and neuropsychological contributions to understanding the schizophrenia spectrum. Proc American College of Neuropsychopharmacology, p115, 1994.

105. Siegel BV, Siever LJ, Trestman RL, Buchsbaum M. Regional brain glucose metabolism in schizotypal personality disorder. Proc American College of Neuropsychopharmacology, p148, 1994.

106. Siegel BV, Siever LJ, Strous R, Trestman RL, Buchsbaum MS. Frontal and striatal volumes in schizotypal personality disorder and schizophrenia assessed with MRI: Neuropsychological and phenomenological correlates. Schizophrenia Research, 15:99, 1995.

107. Siever LJ, Trestman RL, Siegel BV, Losonczy M, Mitropoulou V, Silverman J, Keefe R, Mohs R, Buchsbaum M, Davis KL. Neuroimaging, neurobiological, and neuropsychological abnormalities in SPD: Implications for a model of the schizophrenia spectrum. Schizophrenia Research, 15:99, 1995.

108. *Trestman RL, Buchsbaum M, Siegel BV, Stein D, Shaefer C, Luu C, Siever LJ. Functional neuroimaging in schizotypal personality disorder. Schizophrenia Research, 15:101, 1995.

109. Yehuda, R, Teicher, MH, Levengood, RA, Trestman, RL. HPA axis and catecholamine alterations in PTSD. Proc American Psychiatric Association Annual Meeting, p66, 1995.

110. Siegel, BV, Buchsbaum, M, Siever, LJ, Trestman RL. Dopamine function and MRI measures in schizotypy. Proc American Psychiatric Association Annual Meeting, p76, 1995.

111. *Trestman, RL, Buchsbaum, M, Siegel, BV, Losonczy, M, Schaefer, C, Siever, LJ. Spect imaging of cognition in schizotypals. Symposium Co-Chairman, Proc American Psychiatric Association Annual Meeting, p76, 1995.

112. Falk, J, Trestman, RL, Kahn, R, Siever, LJ. Ipsapirone challenge in personality disorders. Proc American Psychiatric Association Annual Meeting, p54, 1995.

25

25

113. Steinberg, BJ, Yehuda, R, Trestman, RL, Mitropoulou, V, Siever, LJ. Neurobiology of abuse in personality disorders. Proc American Psychiatric Association Annual Meeting, p58, 1995.

114. Steinberg, BJ, Trestman, RL, Mitropoulou, V, Siever LJ. Cholinergic challenges in personality disorders. Proc American Psychiatric Association Annual Meeting, p59, 1995.

115. Falk, J, Trestman, RL, Mitropoulou, V, Siever, LJ. Serotonin and prediction of fluoxetine response time. Proc American Psychiatric Association Annual Meeting, p74, 1995.

116. New, AS, Trestman, RL, Benishay, DS, Coccaro, EF, Siever, LJ. Self-injurious behavior in personality disorders. Proc American Psychiatric Association Annual Meeting, p141, 1995.

117. Stein, DJ, Trestman, RL, Coccaro EF, Mitropoulou, V, Hollander, E, Siever, LJ. Serotonergic responsivity in compulsive personality. Proc American Psychiatric Association Annual Meeting, p190, 1995.

118. Yovell, Y, Gelernter, J, Trestman, RL, Mitropoulou, Erdos, J, Siever, LJ. Tryptophan hydroxylase and impulsive aggression. Proc American Psychiatric Association Annual Meeting, p191, 1995.

119. Grossman, RA, Yehuda, R, Teicher, MH, Levengood, RA, Trestman, RL, Siever, LJ. Chronobiological analysis of prolactin in PTSD. Proc American Psychiatric Association Annual Meeting, p198, 1995.

120. Siegel, BV, Jr., Trestman, RL, Buchsbaum, MS, Luu, C, Shaefer, C, Siever, LJ. Prefrontal activation during the WCST in schizotypal personality. Biological Psychiatry, 37:17, 1995.

121. Steinberg, B, Trestman, RL, Mitropoulou, Siever, LJ. Cholinergic challenge in personality disorders. Biological Psychiatry, 37:18, 1995.

122. Falk, J, Trestman, RL, Kahn, R, Siever, LJ. Ipsapirone as a serotonergic probe in personality disordered patients. Biological Psychiatry, 37:19, 1995

123. Siegel, BV, Jr., Trestman, RL, Mitropoulou, Siever, LJ. D-Amphetamine effects on cognition in schizotypal personality. Biological Psychiatry, 37:20, 1995.

124. Yovell, Y, Siever, LJ, Trestman, RL, Mitropoulou, V, Erdos, J, Gelernter. Tryptophan hydroxylase polymorphism is associated with impulsive aggression. Biological Psychiatry, 37:184, 1995.

125. Stein, DJ, Trestman, RL, Coccaro, E, Mitropoulou, V, Hollander, E, Siever, LJ. Serotonergic responsivity in compulsive personality disorder. Biological Psychiatry, 37:186, 1995.

126. Steinberg, B, Yehuda, R, Trestman, RL, Mitropoulou, V, Siever, LJ. Early abuse and biological measures in personality disorder patients. Biological Psychiatry, 37:231, 1995.

127. New AS, Gelernter J, Trestman RL, Mitropoulou V, Siever LJ. A polymorphism in tryptophan hydroxylase and irritable aggression in personality disorders. Biological Psychiatry, 39:506, 24a, 1996.

128. New AS, Yehuda, R, Steinberg B, Trestman RL, Mitropoulou V, Coccaro E, Siever LJ. Self-reported abuse and biological measures in personality disorders. Biological Psychiatry, 39:535, 121a, 1996.

129. Zale C, New AS, Trestman RL, Mitropoulou V, Siever LJ. Serum cholesterol and impulsive aggressive behavior in personality disorder patients. Biological Psychiatry, 39:535, 122a, 1996.

130. Kirrane R, Trestman RL, Mitropoulou V, Cornblatt B, Siever LJ. Effects of amphetamine on cognitive impairment in schizotypal personality disorder. Biological Psychiatry, 39:581, 280a, 1996.

131. Woo-Ming A, New AS, Mitropoulou V, Trestman RL, Coccaro EF, Siever LJ. Gender differences in noradrenergic and serotonergic studies. Biological Psychiatry, 39:594, 321a, 1996.

132. New AS, Trestman RL, Mitropoulou V, Benishay D, Coccaro E, Siever LJ. Serotonergic function and self-injurious behavior in personality disorders. Proc American Psychiatric Association Annual Meeting, p61, 1996.

133. Woo-Ming A, New AS, Mitropoulou V, Trestman RL, Coccaro EF, Siever LJ. Gender differences in noradrenergic and serotonergic studies. Proc American Psychiatric Association Annual Meeting, p94, NR99, 1996.

134. Zale C, New AS, Trestman RL, Mitropoulou V, Siever LJ. Serum cholesterol and impulsive aggressive behavior in personality disorder patients Proc American Psychiatric Association Annual Meeting, p143, NR280, 1996.

135. Kirrane R, Trestman RL, Mitropoulou V, Cornblatt B, Siever LJ. Effects of amphetamine on cognitive impairment in schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, p144, NR283, 1996.

136. New AS, Gelernter J, Trestman RL, Mitropoulou V, Siever LJ. A polymorphism in tryptophan hydroxylase and irritable aggression in personality disorders. Proc American Psychiatric Assn Annual Meeting, p144, NR284, 1996.

137. New AS, Yehuda, R, Steinberg B, Trestman RL, Mitropoulou V, Coccaro E, Siever LJ. Self-reported abuse and biological measures in personality disorders. Proc American Psychiatric Assn Annual Mtg, p145, NR285, 1996.

138. New AS, Gelernter J, Trestman RL, Siever LJ. Serotonin related genes and impulsive aggression in personality disorders. Proc Amer College Neuropsychopharmacology, p167, 1996.

139. Siever LJ, Trestman RL, New AS, Hazlett E, Sevin E, Buchsbaum M. PET studies and fenfluramine in impulsive patients. 5th International Congress on the Disorders of Personality, VanCouver, BC, June 1997.

140. New AS, Gelernter J, Trestman RL, Mitropoulou V, Siever L. Serotonin related genes and impulsive aggression in personality disorder. 5th International Congress on the Disorders of Personality, VanCouver, BC, June 1997

26

26

141. New AS, Gelernter J, Trestman RL, Siever LJ. Serotonin related genes and impulsive aggression in personality disorder. Biological Psychiatry, 41:186,55S, 1997.

142. Kirrane R, Trestman RL, Mitropoulou V, Nunn M, Siever L. Effects of amphetamine on cognitive impairment in schizotypal personality disorder. Biological Psychiatry, 41:356, 103S, 1997.

143. Woo-Ming AM, Trestman RL, Mitropoulou V, Siever LJ. Biological Psychiatry, 41:416, 119S, 1997. 144. Woo-Ming AM, Trestman RL, New A, Siever L. Responses to clonidine and pre- and post-menopausal women.

Proc American Psychiatric Association Annual Meeting, p110, NR162, 1997. 145. Kirrane R, Trestman RL, Serby M, Mitropoulou V, Siever LJ. Effects of amphetamine on working memory in

schizotypal personality disorder. Proc American Psychiatric Association Annual Meeting, p173, NR394, 1997. 146. New AS, Woo-Ming A, Trestman RL, Siever LJ. Serotonin and prediction of fluoxetine response time. Proc Amer

College Neuropsychopharmacology, p131, 1997. 147. New AS, Gelernter J, Trestman RL, Siever LJ. Serotonin related genes and impulsive aggression in personality

disorders. Proc Amer College Neuropsychopharmacology, p132, 1997. 148. New AS, Gelernter J, Trestman RL, Koenigsberg HL, Siever LJ. Serotonin related genes and impulsive

aggression. Proc American Psychiatric Association Annual Meeting, p78, Symposium 23B, 1998. 149. Trestman, RL, Tennen H, Kranzler, H, Armelli, S, Rounsaville, B. Evaluation of DSM Axis II nosology in substance

abusers. ISSPD 6th International Congress on the Disorders of Personality, Geneva, September, 1999 150. Trestman, RL, Lewis, C. An Academic Model of Correctional Mental Health Care. National Commission on

Correctional Health Care, New Orleans, LA, March, 2000. 151. Trestman, RL, Appelbaum, KL, Rayford, BS, Brower, MC. Academic/Corrections Models of Mental Health Care.

American Psychiatric Association, Chicago, IL, May, 2000. 152. Trestman, RL, Coleman, K., McDonald, C., Bogdanoff, T., Gomez, G., Hashim, A. Behavioral Treatment of the

Aggressive Mentally Ill Inmate. American Psychiatric Association, New Orleans, LA, May, 2001. 153. Appelbaum, K., Trestman, RL, Lewis, CL. Challenging cases in Correctional Psychiatry. American Academy of

Psychiatry & the Law, Boston, MA, October, 2001. 154. Trestman, RL. American College of Neuropsychopharmacology 2001 Annual Meeting. Poster Presentation

Psychopharmacology of Mental Illness in Correctional Setting. December, 2001. 155. Koenigsberg, HW, Goodman, M, New, AS, Mitropoulou, V., Trestman RL, Silverman, J., Siever, LJ. Risperidone

treatment of schizotypal personality disorder. American Psychiatric Association, Philadelphia, PA, May, 2002. 156. Trestman, RL, Bannish, D., Chaplin, P. Implementation of DBT in Correctional Environments. American

Psychiatric Association, Philadelphia, PA, May, 2002. 157. Trestman RL. Empirical Development of Mental Health Screening. Invited presentation at the annual Research &

Evaluation conference co-sponsored by the National Institute of Justice, July 2002 158. Appelbaum K, Trestman, RL. Medical Schools and Correctional Mental Health. American Academy of Psychiatry

& Law, Newport Beach, CA, October 2002. 159. Bergman A, Trestman RL. Epidemiology and treatment of co-occurring addictive disorders and mental illness in

incarcerated populations: A review of the field. American Academy of Addictions Psychiatrists, December 2002. 160. Hogan VS, Trestman RL, Bannish D, Chaplin P. Developing forensic DBT: the utilization of Dialectical Therapy

components with difficult to manage correctional populations. National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism “Beyond the Clinic Walls” (poster presentation), March 2003

161. Trestman RL, Hogan VS, Ford J. The development of a brief mental health screening tool. National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism “Beyond the Clinic Walls” (poster presentation), March 2003

162. Trestman RL, Hogan VS, Ford J. The development of a brief mental health screening tool. Annual conference of the American Psychiatric Association, San Francisco, CA, May 2003.

163. Trestman RL. The development and validation of a brief and efficient mental health screen for corrections: products and updates. Invited presentation at the annual Research & Evaluation conference co-sponsored by the National Institute of Justice, July 2003.

164. Trestman, RL, Norko, MA, Hanson, AL, Champion, MK. The many interfaces of correctional mental health. Workshop: Annual meeting of the American Academy of Psychiatry & the Law, San Antonio, TX, October, 2003..

165. Temporini, HD, Hogan, VS, Trestman, RL. Dialectical Behavior Therapy in a maximum security prison: Effects on problem behavior. Annual meeting of the American Academy of Psychiatry & the Law, San Antonio, TX, Oct, 2003.

166. Trestman RL, Ford JD, Hogan V, Quarti S. Epidemiology of, and Development of a Brief Screen for, Personality Disorders in Jails. VIII International ISSPD Congress, Florence. October 2003.

167. Trestman RL, Hogan VS, Bannish D, Berzins L. Adaptation and Use of DBT in Correctional Settings: Current Status and Future Directions. VIII International ISSPD Congress, Florence. October 2003.

27

27

168. Magaletta P, Scott JE, Trestman RL, Vanyur J. Improving Correctional Mental Health Services: Brief Mental Health Screening Instruments for Jail Detainees and Prison Inmates. American Correctional Assn January 2004.

169. Ford, JD, Hogan, VS, Trestman, RL, Quarti, S, Temporini, HD. Development of a brief and efficient mental health screen for jails. American Psychiatric Association, May, 2004.

170. Trestman RL, Berzins L, Hogan VS. Developing Forensic DBT: Implementation of Dialectical Behavior Therapy with Difficult to Manage Correctional Populations. IAFMHS Conference, Stockholm June 2004

171. Trestman RL, Ford JD, Hogan VS. Development of a short and efficient mental health screening tool for jail settings. IAFMHS Conference, Stockholm June 2004.

172. Trestman RL. Development of corrections modified dialectical behavior therapy. National Institute of Justice annual conference on criminal Justice research and evaluation. Washington DC July 2004.

173. Buscema CA, Dillon JE, Silberberg JM, Thompson JW, Trestman RL. Workshop: Treatment Algorithms in the Correctional Setting. Annual meeting of the Amer Acad of Psychiatry & the Law, Scottsdale AZ, October, 2004.

174. Trestman RL, Candilis PJ, Silberberg JM, Temporini HD. Workshop: The Fundamentals of Correctional Mental Health Research. Annual meeting of the Amer Academy of Psychiatry & the Law, Scottsdale AZ, October, 2004.

175. Trestman RL. The Development of Corrections Modified Dialectical Behavior Therapy. NIDA, “Developing Efficacious Behavioral Therapies for Criminal Justice Involved Populations.” Gaithersburg MD, December 2004

176. Trestman RL, Sampl S, Davis K and Gonillo C. Adaptation and use of DBT in Correctional Settings. Annual Meeting, International Society for the Study of Personality Disorders, Buenos Aires, Argentina, April 21, 2005

177. Trestman RL, Ford J, Hogan, and Quarti S. Epidemiology of Personality Disorders in Connecticut Jails. Annual Meeting, International Society for the Study of Personality Disorders, Buenos Aires, Argentina, April 23, 2005

178. Trestman RL, Candilis PJ, Silberberg JM, Temporini HD. Meeting the Challenges of Correctional Mental Health Research . Annual meeting of the American Psychiatric Association, Atlanta GA, May, 2005.

179. Trestman RL Psychopharmacology Management and Interventions Research in Corrections. Annual meeting of the American Psychiatric Association, Atlanta GA, May, 2005.

180. Trestman RL, Sampl S, Gonillo C, Davis K. Adaptation of DBT for Correctional Settings: Preliminary Findings. NIMH Annual Mental Health Services Research Conference, Washington DC, July 2005.

181. McLearen A, Trestman RL, Denney D, Farman S. Applying DBT in Correctional Settings- State, Federal and International perspectives. American Psychological Association Annual Meeting, Washington DC, August 2005.

182. Buscema C, Thompson J, Trestman RL Forensic Treatment Algorithms for the Treatment of Bipolar Disorder. Annual meeting of the American Academy of Psychiatry & the Law, Montreal CA, October, 2005.

183. Appelbaum K, Trestman RL, Metzner J, Benson A. Workshop: The Pros and Cons of Prescribing Controlled Substances in Prisons. Annual meeting of the Amer Acad of Psychiatry & the Law, Montreal CA, October, 2005.

184. Butterfield P, Fishbein D, Trestman RL. Evidence based Mental Health Treatment in Corrections. American Criminal Justice Society Annual Meeting, Baltimore MD, March, 2006.

185. Trestman RL, Ford J, Zhang W, Pagano K, Development and Validation of a Correctional Mental Health Screen, 7th Annual Conference, International Association of Forensic Mental Health Services, Amsterdam, June 14, 2006.

186. Trestman RL, Zhang W, Ford J, Pagano K, Prevalence of Mental Illness in Connecticut Jails, 7th Annual Conference, International Association of Forensic Mental Health Services, Amsterdam Netherlands, June 14, 2006.

187. Gorey J, Trestman RL, Widom C, Gaes G. Does IRB oversight improve prisoner research? National Institute of Justice Research Conference, Washington DC, July 17, 2006

188. Trestman RL. Personality disorders in the incarcerated population. National Education Alliance for Bipolar Disorders Conference (NEABPD). (Sponsored by NIMH) Charleston, SC October 14-15 2006

189. Trestman RL, Demartinis N, Pagano K, Zhang W, Temporini H. Re-Arrest and Re-Incarceration of the Mentally ill in CT: 1998-2004. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, Oct 2006.

190. Trestman RL, Ford J, Zhang W, Pagano K. Prevalence of Mental Illness in Connecticut’s Jails. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

191. Trestman RL, Sampl S, Zhang W, Pagano K. DBT-informed treatment for impulsive aggression in corrections: A pilot study. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

192. Trestman RL, Ford J, Zhang W. Development of a brief mental health screening instrument for newly incarcerated adults. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

193. Trestman RL, Demartinis N, Elsamra M, Zhang W. Impact of provider feedback and utilization review in corrections. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

194. Hashmi S, Trestman RL, Zhang W, Pagano K. The Relationship Between BPD and Violent Offenses. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

195. Quanbeck CD, McDermott B, Trestman RL. The history, ethics and future of research involving prisoners. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 26-29, 2006.

28

28

196. Trestman RL. START NOW: A cognitive Behavioral Intervention for Offenders with Behavioral Disorders. Fifth World Congress of Behavioral and Cognitive Therapies, Barcelona Spain, July 12-14, 2007

197. Fishbein D, Trestman RL, Sampl SJ. Mentally Ill Prisoners: Breakthroughs in Assessment and Treatment. NIJ Conference 2007, Arlington VA, July 23-25,

198. Trestman RL. Adapting Evidence Based CBT Practices for Justice Involved Persons. CMHS National GAINS Center Conference, Bethesda MD, September 6, 2007

199. Rivera K, Zhang W, Pagano K, Trestman RL. Factors in psychotherapy Adherence in Offenders, Annual meeting of the American Academy of Psychiatry & the Law, Miami Beach, FL, October 18-21, 2007.

200. Trestman RL. Scott C, Ash P, Rosner R, Weinstock R. Developing a Research Curriculum for Forensic Psychiatry Fellowships. Annl mtg of the American Academy of Psychiatry & the Law, Miami Beach, FL, October 18-21, 2007.

201. Appelbaum K, Trestman RL. Prison Research: Opportunities, Hurdles, Methods. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 23-26, 2008.

202. Helfand S, Trestman RL. Suicide Prevention PI in Corrections: The Six Sigma Method. Annual meeting of the American Academy of Psychiatry & the Law, Chicago IL, October 23-26, 2008.

203. Trestman RL, Potter RH, Noonan AS, May JP. Coping with Fiscal Realities in Correctional Healthcare. Annual Mtg of the American Correctional Health Services Association, Orlando FL, March 13 2009

204. Trestman RL, Potter RH, Lanier MM, McCuan R. Translation of Evidence-based Practice into Policy Changes in Correctional Health Care. Annual Mtg of the Amer Corr Health Srvs Association, Orlando FL, March 13 2009

205. Trestman RL, Spaulding A, McCuan R, Lanier MM. Research Ethics in Corrections. Annual Mtg of the American Correctional Health Services Association, Orlando FL, March 14 2009

206. Trestman RL, Helfand S, Gallagher C. Suicide prevention: Performance Improvement Using the Six Sigma Method. International Association of Forensic Mental Health Services, Edinburgh, Scotland, June 25, 2009

207. Trestman RL, Ford J, Kesten K, Zhang W. Validation of the correctional mental health screen. International Association of Forensic Mental Health Services, Edinburgh, Scotland, June 26, 2009

208. Trestman RL, Temporini H, Kamath J, Kesten K, Zhang W. Evidence-based decision support for the treatment of bipolar disorder in correctional populations. International Association of Forensic Mental Health Services, Edinburgh, Scotland, June 26, 2009

209. Trestman RL, Sampl S, Wakai S, Keeney E. The Correctional application of group-facilitated functional analysis. International Association of Forensic Mental Health Services, Edinburgh, Scotland, June 26, 2009

210. Ford J, Kesten K, Trestman RL, Zhang W. Validation of the Correctional Mental Health Screen. Annual meeting of the American Academy of Psychiatry & the Law, Baltimore MD, October 29 - November 1, 2009.

211. Trestman RL, Keeney E, Sampl S, Wakai S. Correctional Group-Facilitated Functional Analysis. Annual meeting of the American Academy of Psychiatry & the Law, Baltimore MD, October 29 - November 1, 2009.

212. Trestman RL, Shelton D, Wakai S. A process Evaluation of the Implementation of START NOW. Annual meeting of the American Academy of Psychiatry & the Law, Baltimore MD, October 29 - November 1, 2009.

213. Trestman RL. The Corrections Modified GAF. Annual meeting of the American Academy of Psychiatry & the Law, Tucson AZ, Oct 20-24 2010.

214. Wang S, Felthous A, Young J, Trestman RL. Implications of a National Institute of Forensic Sciences. The Corrections Modified GAF. Annual mtg American Academy of Psychiatry & the Law, Tucson AZ, Oct 20-24 2010.

215. Gunter T, Black D, Trestman RL. Practical Research Issues and Opportunities in Correctional Settings. Annual meeting of the American Academy of Psychiatry & the Law, Tucson AZ, Oct 20-24 2010.

216. Trestman RL, Juliano-Bult D, Mulvey E, Bradford J. APLS/AAPL Research Collaboration. Annual meeting of the American Academy of Psychiatry & the Law, Tucson AZ, Oct 20-24 2010.

217. Appelbaum K, Savagieux J, Trestman RL, Metzner J. “National Survey of Self Injurious Behavior in Prison Settings,” 4th Academic and Health Policy Conference on Correctional Health, Boston MA, March 10,2011

218. JW Swanson, MS Swartz, A Gilbert, LK Frisman, RL Trestman, Costs of Criminal Justice Involvement and Service Utilization among Persons with Severe Mental Illness in Connecticut. APHA 139th Annual Mtg, Washington DC, Oct 29 – Nov 2, 2011.

219. Trestman R.L., Barry L. Double-jeopardy: Mental illness and poor physical function in CT Prisoners. 5th Annual Academic & Health Policy Conference on Correctional Health, Atlanta, GA March 22-23, 2012.

220. Appelbaum, K., Metzner, J., Trestman, R.L. Optimizing mental health care – What’s known and not known about efficient and effective care delivery. 5th Annual Academic & Health Policy Conference on Correctional Health, Atlanta, GA March 22-23, 2012.

221. Magley, V.J., Walsh, B.M., Trestman, R.L., & Dinnan, M. (May, 2012). Initial Evaluation of the Civility Among Healthcare Professionals (CAHP) Workshop. Paper presented at the National Conference for Workplace Violence Prevention and Management in Healthcare Settings, Cincinnati, OH.

29

29

222. Kaufman, A., Mossman, D., Hall, R., Trestman, R. (October, 2012). Beyond a Reasonable Doubt: Evidence-Based Expert Opinions. Paper presented at the 43rd Annual Meeting of the American Academy of Psychiatry & the Law, Montreal, Canada.

223. Trestman, R.L., Appelbaum, K., Metzner, J. “Making Things Better: Academic Views About Consultative and Judicial Impact on Correctional Healthcare.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

224. Sampl, S., Trestman, R.L., Shea, K., Varma, M., Krauss, W., & Houde, A. “Start Now: Implementing and Evaluating a Cognitive Behavioral Intervention for Offenders.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

225. Wang, E., Aminawung, J., Ferguson, W., Trestman, R.L., Wagner, E., Bova, C. “Assessing Chronic Illness Care in Prison.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

226. Cislo, A., Ehret, M., Trestman, R.L. “Metabolic Syndrome in a Corrections Population Treated With Antipsychotics.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

227. Kamath, J., Trestman, R.L. “Adaptation of Cancer Supportive Care to the Correctional Setting: A Proposed Model.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

228. Pettigrew, C., Tapia, S., Trestman, R.L. “Collaborating for Quality and Safety: Implementing Therapeutic Phlebotomy in Connecticut Correctional Infirmaries.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

229. Barry, L., Trestman, R.L. “Disability and Suicidal Ideation in Older Prisoners: A Pilot Study.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

230. Trestman, R.L., Coleman, K.C., Krauss, W. “The Development of a Suicide Prevention Physical Plant Audit Process in Connecticut’s Juvenile Residential Services.” Academic & Health Policy Conference on Correctional Health in Chicago, IL, March 19-22, 2013.

231. Hennig, B., Trestman, R.L. “Statewide Collaboration between a Correctional System and a Huntington’ Disease Clinical Program.” 2013 World Congress on Huntington’s Disease, Rio de Janeiro, Brazil, September 15-18, 2013.

232. Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Longitudinal Treatment Outcomes in HIV-Infected Prisoners and Influence of Re-Incarceration, CROI, Boston MA, March 4, 2014.

233. Appelbaum, K., Metzner, J., Trestman, R.L. “Should Mental Health Clinical and Ethical Standards Differ in Correctional Settings?” 7th Academic & Health Policy Conference on Correctional Health in Houston, TX March 20-21, 2014.

234. Thomas, D., Trestman, R.L., Wu, J. “Correctional Fellowships” 7th Academic & Health Policy Conference on Correctional Health in Houston, TX March 20-21, 2014.

235. Shelton, D., Trestman, R.L., Cislo, A., Ehret, M. “Building Sustainable Research Teams with Correctional Partners” 7th Academic & Health Policy Conference on Correctional Health in Houston, TX March 20-21, 2014.

236. Appelbaum, K., Trestman, R.L., Metzner, J., “Correctional Mental Health: Historical Development of Existing Guidelines and Their Limitations Regarding Emerging Issues.” 7th Academic & Health Policy Conference on Correctional Health in Houston, TX March 20-21, 2014.

237. Cislo, A., Kersten, L., Trestman, R.L., Sampl, S., Le, Hoe, Shea, K. “Start Now: An Evidence-Informed Group Therapy for Inmates with Behavioral Disorders.” 7th Academic & Health Policy Conference on Correctional Health in Houston, TX March 20-21, 2014.

238. Tamburello, A., Metzner, J., Roskes, E., Trestman, R.L. American Academy of Psychiatry and the Law Annual Meeting, “Correctional Psychiatry for the Forensic Psychiatrist” Chicago, IL October 21-26, 2014.

239. Trestman, R.L. “START NOW: Development and Implementation of a Skills-Based Psychotherapy for Correctional Settings”, Edinburgh, Scotland, November 11, 2014.

240. Trestman, R.L. Presentation at the Institute for Biomedical Ethics, Basel, Switzerland, November 13, 2014 241. Trestman, R.L. “Correctional Mental Health: A Best Practices Sampler.” New York State Correctional Mental

Health Staff, December 10, 2014. 242. Barry, L., Trestman, R.L., Wakefield, D., Conwell, Y. “Disability in Prison Activities of Daily Living and Suicidal

Ideation in Older Inmates”. Presentation at the American Association for Geriatric Psychiatry, 2015 Annual Meeting, New Orleans, LI, March 29, 2015.

243. Trestman, R.L., Appelbaum, K., Metzner, J. Evolution of Correctional Psychiatry: A Curriculum for the Next Generation of Correctional Psychiatrists. 8th Academic & Health Policy Conference on Correctional Health in Boston MA, March 19, 2015.

244. Virdi, S., Trestman, R.L. Personality Disorders in the Corrections Population. 8th Academic & Health Policy Conference on Correctional Health in Boston MA, March 20, 2015.

245. Appelbaum, K., Ford, E., Metzner, J., Penn, J., Trestman, R.L. American Academy of Psychiatry and the Law Annual Meeting, “The New APA Guidelines on Correctional Psychiatry”, Fort Lauderdale, FL, October 22-25, 2015.

30

30

246. Minhas, H., Mazhar, M., Azhar, H., Fatima, M., Trestman, R.L. American Academy of Psychiatry and the Law Annual Meeting, “A Review of Forensic Psychiatric Practices in Pakistan”, Fort Lauderdale, FL, October 22-25, 2015.

247. Appelbaum, K., Metzner, J., Trestman, R.L. American Academy of Psychiatry and the Law Annual Meeting, “A Correctional Psychiatry Curriculum for the Next Generation”, Fort Lauderdale, FL, October 22-25, 2015.

248. Trestman RL, Wright J. START NOW: Gender Specific Modification for Women. 9th Academic & Health Policy Conference on Correctional Health, Baltimore, MD March 16-18, 2016

249. Trestman RL. Development and Implementation of a Correctional Skills-Based Psychotherapy: START NOW, American Psychiatric Association Annual Meeting, Atlanta GA, May 14, 2016.

250. Trestman RL, Wright J. START NOW: A skills-based intervention for impulsivity and affective lability. American Academy of Child and Adolescent Psychiatry, New York, NY October26, 2016.

251. Trestman RL, Funding of Research, American Academy of Psychiatry and the Law Annual Conference, Portland, OR, October 28, 2016.

252. Trestman RL. START NOW: From research to implementation to broad dissemination, 10th Academic & Health Policy Conference on Correctional Health, Atlanta GA, March 16, 2017.

TRESTMAN CV 03282017.docx